{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T07:39:47Z","timestamp":1777189187845,"version":"3.51.4"},"reference-count":787,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:00:00Z","timestamp":1535328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/ejcts\/ezy289","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T10:03:46Z","timestamp":1535364226000},"page":"4-90","source":"Crossref","is-referenced-by-count":456,"title":["2018 ESC\/EACTS Guidelines on myocardial revascularization"],"prefix":"10.1093","volume":"55","author":[{"given":"Miguel","family":"Sousa-Uva","sequence":"first","affiliation":[]},{"given":"Franz-Josef","family":"Neumann","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Ahlsson","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Alfonso","sequence":"additional","affiliation":[]},{"given":"Adrian P","family":"Banning","sequence":"additional","affiliation":[]},{"given":"Umberto","family":"Benedetto","sequence":"additional","affiliation":[]},{"given":"Robert A","family":"Byrne","sequence":"additional","affiliation":[]},{"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[]},{"given":"Volkmar","family":"Falk","sequence":"additional","affiliation":[]},{"given":"Stuart J","family":"Head","sequence":"additional","affiliation":[]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[]},{"given":"Akos","family":"Koller","sequence":"additional","affiliation":[]},{"given":"Steen D","family":"Kristensen","sequence":"additional","affiliation":[]},{"given":"Josef","family":"Niebauer","sequence":"additional","affiliation":[]},{"given":"Dimitrios J","family":"Richter","sequence":"additional","affiliation":[]},{"given":"Petar M","family":"Seferovi\u0107","sequence":"additional","affiliation":[]},{"given":"Dirk","family":"Sibbing","sequence":"additional","affiliation":[]},{"given":"Giulio G","family":"Stefanini","sequence":"additional","affiliation":[]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[]},{"given":"Rashmi","family":"Yadav","sequence":"additional","affiliation":[]},{"given":"Michael O","family":"Zembala","sequence":"additional","affiliation":[]},{"name":"ESC Scientific Document Group","sequence":"additional","affiliation":[]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[]},{"given":"David","family":"Glineur","sequence":"additional","affiliation":[]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[]},{"given":"Stephan","family":"Achenbach","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Agewall","sequence":"additional","affiliation":[]},{"given":"Felicita","family":"Andreotti","sequence":"additional","affiliation":[]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[]},{"given":"Andreas","family":"Baumbach","sequence":"additional","affiliation":[]},{"given":"James","family":"Brophy","sequence":"additional","affiliation":[]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[]},{"given":"Patrick A","family":"Calvert","sequence":"additional","affiliation":[]},{"given":"Davide","family":"Capodanno","sequence":"additional","affiliation":[]},{"given":"Piroze M","family":"Davierwala","sequence":"additional","affiliation":[]},{"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[]},{"given":"Dariusz","family":"Dudek","sequence":"additional","affiliation":[]},{"given":"Nick","family":"Freemantle","sequence":"additional","affiliation":[]},{"given":"Christian","family":"Funck-Brentano","sequence":"additional","affiliation":[]},{"given":"Oliver","family":"Gaemperli","sequence":"additional","affiliation":[]},{"given":"Stephan","family":"Gielen","sequence":"additional","affiliation":[]},{"given":"Martine","family":"Gilard","sequence":"additional","affiliation":[]},{"given":"Bulent","family":"Gorenek","sequence":"additional","affiliation":[]},{"given":"Joerg","family":"Haasenritter","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Haude","sequence":"additional","affiliation":[]},{"given":"Borja","family":"Ibanez","sequence":"additional","affiliation":[]},{"given":"Bernard","family":"Iung","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Jeppsson","sequence":"additional","affiliation":[]},{"given":"Demosthenes","family":"Katritsis","sequence":"additional","affiliation":[]},{"given":"Juhani","family":"Knuuti","sequence":"additional","affiliation":[]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[]},{"given":"Adelino","family":"Leite-Moreira","sequence":"additional","affiliation":[]},{"given":"Lars H","family":"Lund","sequence":"additional","affiliation":[]},{"given":"Francesco","family":"Maisano","sequence":"additional","affiliation":[]},{"given":"Julinda","family":"Mehilli","sequence":"additional","affiliation":[]},{"given":"Bernhard","family":"Metzler","sequence":"additional","affiliation":[]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[]},{"given":"Domenico","family":"Pagano","sequence":"additional","affiliation":[]},{"given":"Anna Sonia","family":"Petronio","sequence":"additional","affiliation":[]},{"given":"Massimo Francesco","family":"Piepoli","sequence":"additional","affiliation":[]},{"given":"Bogdan A","family":"Popescu","sequence":"additional","affiliation":[]},{"given":"Rafael","family":"S\u00e1daba","sequence":"additional","affiliation":[]},{"given":"Evgeny","family":"Shlyakhto","sequence":"additional","affiliation":[]},{"given":"Sigmund","family":"Silber","sequence":"additional","affiliation":[]},{"given":"Iain A","family":"Simpson","sequence":"additional","affiliation":[]},{"given":"David","family":"Sparv","sequence":"additional","affiliation":[]},{"given":"Giuseppe","family":"Tavilla","sequence":"additional","affiliation":[]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[]},{"given":"Petr","family":"Tousek","sequence":"additional","affiliation":[]},{"given":"Eric","family":"Van Belle","sequence":"additional","affiliation":[]},{"given":"Pascal","family":"Vranckx","sequence":"additional","affiliation":[]},{"given":"Adam","family":"Witkowski","sequence":"additional","affiliation":[]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[]},{"given":"Victor","family":"Aboyans","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Agewall","sequence":"additional","affiliation":[]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Coca","sequence":"additional","affiliation":[]},{"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[]},{"given":"Ioan Mircea","family":"Coman","sequence":"additional","affiliation":[]},{"given":"Veronica","family":"Dean","sequence":"additional","affiliation":[]},{"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[]},{"given":"Donna","family":"Fitzsimons","sequence":"additional","affiliation":[]},{"given":"Oliver","family":"Gaemperli","sequence":"additional","affiliation":[]},{"given":"Gerhard","family":"Hindricks","sequence":"additional","affiliation":[]},{"given":"Bernard","family":"Iung","sequence":"additional","affiliation":[]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[]},{"given":"Hugo A","family":"Katus","sequence":"additional","affiliation":[]},{"given":"Juhani","family":"Knuuti","sequence":"additional","affiliation":[]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[]},{"given":"Christophe","family":"Leclercq","sequence":"additional","affiliation":[]},{"given":"Theresa A","family":"McDonagh","sequence":"additional","affiliation":[]},{"given":"Massimo Francesco","family":"Piepoli","sequence":"additional","affiliation":[]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[]},{"given":"Dimitrios J","family":"Richter","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[]},{"given":"Evgeny","family":"Shlyakhto","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Sousa-Uva","sequence":"additional","affiliation":[]},{"given":"Iain A","family":"Simpson","sequence":"additional","affiliation":[]},{"given":"Jose Luis","family":"Zamorano","sequence":"additional","affiliation":[]},{"given":"Domenico","family":"Pagano","sequence":"additional","affiliation":[]},{"given":"Nick","family":"Freemantle","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"Sousa-Uva","sequence":"additional","affiliation":[]},{"given":"Mohamed","family":"Chettibi","sequence":"additional","affiliation":[]},{"given":"Hamayak","family":"Sisakian","sequence":"additional","affiliation":[]},{"given":"Bernhard","family":"Metzler","sequence":"additional","affiliation":[]},{"given":"Firdovsi","family":"\u0130brahimov","sequence":"additional","affiliation":[]},{"given":"Valeriy I","family":"Stelmashok","sequence":"additional","affiliation":[]},{"given":"Arman","family":"Postadzhiyan","sequence":"additional","affiliation":[]},{"given":"Bosko","family":"Skoric","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Eftychiou","sequence":"additional","affiliation":[]},{"given":"Petr","family":"Kala","sequence":"additional","affiliation":[]},{"given":"Christian Juhl","family":"Terkelsen","sequence":"additional","affiliation":[]},{"given":"Ahmed","family":"Magdy","sequence":"additional","affiliation":[]},{"given":"Jaan","family":"Eha","sequence":"additional","affiliation":[]},{"given":"Matti","family":"Niemel\u00e4","sequence":"additional","affiliation":[]},{"given":"Sasko","family":"Kedev","sequence":"additional","affiliation":[]},{"given":"Pascal","family":"Motreff","sequence":"additional","affiliation":[]},{"given":"Alexander","family":"Aladashvili","sequence":"additional","affiliation":[]},{"given":"Julinda","family":"Mehilli","sequence":"additional","affiliation":[]},{"given":"Ioannis-Georgios","family":"Kanakakis","sequence":"additional","affiliation":[]},{"given":"David","family":"Becker","sequence":"additional","affiliation":[]},{"given":"Thorarinn","family":"Gudnason","sequence":"additional","affiliation":[]},{"given":"Aaron","family":"Peace","sequence":"additional","affiliation":[]},{"given":"Francesco","family":"Romeo","sequence":"additional","affiliation":[]},{"given":"Gani","family":"Bajraktari","sequence":"additional","affiliation":[]},{"given":"Alina","family":"Kerimkulova","sequence":"additional","affiliation":[]},{"given":"Ain\u0101rs","family":"Rudz\u012btis","sequence":"additional","affiliation":[]},{"given":"Ziad","family":"Ghazzal","sequence":"additional","affiliation":[]},{"given":"Aleksandras","family":"Kibarskis","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[]},{"given":"Robert G","family":"Xuereb","sequence":"additional","affiliation":[]},{"given":"Sjoerd H","family":"Hofma","sequence":"additional","affiliation":[]},{"given":"Terje K","family":"Steigen","sequence":"additional","affiliation":[]},{"given":"Adam","family":"Witkowski","sequence":"additional","affiliation":[]},{"given":"Eduardo Infante","family":"de Oliveira","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Mot","sequence":"additional","affiliation":[]},{"given":"Dmitry","family":"Duplyakov","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Zavatta","sequence":"additional","affiliation":[]},{"given":"Branko","family":"Beleslin","sequence":"additional","affiliation":[]},{"given":"Frantisek","family":"Kovar","sequence":"additional","affiliation":[]},{"given":"Matja\u017e","family":"Bunc","sequence":"additional","affiliation":[]},{"given":"Soledad","family":"Ojeda","sequence":"additional","affiliation":[]},{"given":"Nils","family":"Witt","sequence":"additional","affiliation":[]},{"given":"Raban","family":"Jeger","sequence":"additional","affiliation":[]},{"given":"Faouzi","family":"Addad","sequence":"additional","affiliation":[]},{"given":"Ramazan","family":"Akdemir","sequence":"additional","affiliation":[]},{"given":"Alexander","family":"Parkhomenko","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Henderson","sequence":"additional","affiliation":[]}],"member":"286","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"2025110203570931700_ezy289-B1","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B2","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/2012.jama.11274","article-title":"Diagnostic accuracy of fractional flow reserve from anatomic CT angiography","volume":"308","author":"Min","year":"2012","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B3","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jacc.2013.11.043","article-title":"Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: The NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps","volume":"63","author":"Norgaard","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B4","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1093\/eurheartj\/ehv444","article-title":"Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs usual care in patients with suspected coronary artery disease: The prospective longitudinal trial of FFR(CT): Outcome and resource impacts study","volume":"36","author":"Douglas","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B5","first-page":"2129","article-title":"ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J"},{"key":"2025110203570931700_ezy289-B6","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09.006","article-title":"PARR-2 Investigators. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2","volume":"50","author":"Beanlands","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"International Society for Heart Lung Transplantation Infectious Diseases Council, International Society for Heart Lung Transplantation Pediatric Transplantation Council, International Society for Heart Lung Transplantation Heart Failure, Transplantation Council. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"2025110203570931700_ezy289-B8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2025110203570931700_ezy289-B9","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCIMAGING.112.000138","article-title":"Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: Inducible ischemia versus hibernating myocardium","volume":"6","author":"Ling","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025110203570931700_ezy289-B12","first-page":"2241","article-title":"IRIS-FFR Investigators. Fractional flow reserve and cardiac events in coronary artery disease","volume":"135","author":"Ahn","year":"2017","journal-title":"Data from a prospective IRIS-FFR Registry (Interventional Cardiology Research Incooperation Society Fractional Flow Reserve). Circulation"},{"key":"2025110203570931700_ezy289-B13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0735-1097(98)00050-3","article-title":"Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement","volume":"31","author":"Bech","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B14","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1161\/01.CIR.103.24.2928","article-title":"Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: A randomized trial","volume":"103","author":"Bech","year":"2001","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B15","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2007.01.087","article-title":"Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study","volume":"49","author":"Pijls","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.115.018747","article-title":"Significance of intermediate values of fractional flow reserve in patients with coronary artery disease","volume":"133","author":"Adjedj","year":"2016","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B17","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","article-title":"Use of the instantaneous wave-free ratio or fractional flow reserve in PCI","volume":"376","author":"Davies","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B18","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","article-title":"iFR-SWEDEHEART Investigators. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI","volume":"376","author":"Gotberg","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/CIRCULATIONAHA.113.006646","article-title":"Investigators of the Registre Francais de la FFR\u2013R3F. Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: Insights from a large French multicenter fractional flow reserve registry","volume":"129","author":"Van Belle","year":"2014","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/CIRCINTERVENTIONS.113.000978","article-title":"Does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain? the RIPCORD study","volume":"7","author":"Curzen","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B21","doi-asserted-by":"crossref","first-page":"e003288","DOI":"10.1161\/CIRCINTERVENTIONS.115.003288","article-title":"Impact of routine fractional flow reserve evaluation during coronary angiography on management strategy and clinical outcome: One-year results of the POST-IT","volume":"9","author":"Baptista","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B22","doi-asserted-by":"crossref","first-page":"e004296","DOI":"10.1161\/CIRCINTERVENTIONS.116.004296","article-title":"Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes: PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice)","volume":"10","author":"Van Belle","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B23","doi-asserted-by":"crossref","first-page":"e004137","DOI":"10.1161\/CIRCINTERVENTIONS.116.004137","article-title":"Routine fractional flow reserve combined to diagnostic coronary angiography as a one-stop procedure: Episode 3","volume":"9","author":"Van Belle","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B24","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jacc.2014.07.973","article-title":"Prognostic value of fractional flow reserve: Linking physiologic severity to clinical outcomes","volume":"64","author":"Johnson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B25","first-page":"12","article-title":"Long-term outcomes following fractional flow reserve-guided treatment of angiographically ambiguous left main coronary artery disease: A meta-analysis of prospective cohort studies","volume":"86","author":"Mallidi","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B26","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCULATIONAHA.109.850073","article-title":"Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis","volume":"120","author":"Hamilos","year":"2009","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCINTERVENTIONS.112.000104","article-title":"Fractional flow reserve assessment of left main stenosis in the presence of downstream coronary stenoses","volume":"6","author":"Yong","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B28","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1161\/CIRCULATIONAHA.113.002740","article-title":"Fractional flow reserve-guided versus angiography-guided coronary artery bypass graft surgery","volume":"128","author":"Toth","year":"2013","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B29","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"van' t Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF; FAME Study Investigators. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2010.04.012","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study","volume":"56","author":"Pijls","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B31","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(15)00057-4","article-title":"Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial","volume":"386","author":"van Nunen","year":"2015","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.117.031907","article-title":"FAME 2 Trial Investigators. Clinical outcomes and cost-effectiveness of fractional flow reserve-guided percutaneous coronary intervention in patients with stable coronary artery disease: Three-year follow-up of the FAME 2 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation)","volume":"137","author":"Fearon","year":"2018","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B34","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1093\/eurheartj\/ehx512","article-title":"Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study","volume":"38","author":"Escaned","year":"2017","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B34a","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jacc.2012.12.012","article-title":"FIRST: Fractional Flow Reserve and Intravascular Ultrasound Relationship Study","volume":"61","author":"Waksman","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/CIRCINTERVENTIONS.108.799494","article-title":"MAIN-COMPARE Investigators. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis","volume":"2","author":"Park","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jacc.2004.09.066","article-title":"Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: A long-term follow-up study","volume":"45","author":"Fassa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2011.02.064","article-title":"LITRO Study Group. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study","volume":"58","author":"de la Torre Hernandez","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B38","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jcin.2014.02.015","article-title":"Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis","volume":"7","author":"Park","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B39","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJM199606273342604","article-title":"Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses","volume":"334","author":"Pijls","year":"1996","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/hex.12636","article-title":"Exploring patient-reported outcomes following percutaneous coronary intervention: A qualitative study","volume":"21","author":"Ayton","year":"2018","journal-title":"Health Expect"},{"key":"2025110203570931700_ezy289-B41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1051\/ject\/201446023","article-title":"Meaningful outcome measures in cardiac surgery","volume":"46","author":"Myles","year":"2014","journal-title":"J Extra Corpor Technol"},{"key":"2025110203570931700_ezy289-B42","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B43","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/eurheartj\/eht059","article-title":"The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease","volume":"34","author":"Head","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/euhj.2000.2282","article-title":"The consequences of under-use of coronary revascularization; Results of a cohort study in Northern Italy","volume":"22","author":"Filardo","year":"2001","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jtcvs.2013.01.026","article-title":"Impact of European Society of Cardiology and European Association for Cardiothoracic Surgery Guidelines on Myocardial Revascularization on the activity of percutaneous coronary intervention and coronary artery bypass graft surgery for stable coronary artery disease","volume":"147","author":"Yates","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B46","author":"Organisation for Economic Co-operation and Development"},{"key":"2025110203570931700_ezy289-B47","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.114.015156","article-title":"Temporal trends in percutaneous coronary intervention appropriateness: Insights from the clinical outcomes assessment program","volume":"132","author":"Bradley","year":"2015","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B48","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jacc.2016.12.025","article-title":"Changes in percutaneous coronary interventions deemed \"inappropriate\" by appropriate use criteria","volume":"69","author":"Hannan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B49","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1749-8090-1-2","article-title":"Variations in clinical decision-making between cardiologists and cardiac surgeons; A case for management by multidisciplinary teams?","volume":"1","author":"Denvir","year":"2006","journal-title":"J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2016.01.041","article-title":"Implementation and consistency of Heart Team decision-making in complex coronary revascularisation","volume":"206","author":"Pavlidis","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025110203570931700_ezy289-B51","first-page":"E103","article-title":"Revascularization heart team recommendations as an adjunct to appropriate use criteria for coronary revascularization in patients with complex coronary artery disease","volume":"88","author":"Sanchez","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1749-8090-8-74","article-title":"The occurrence of adverse events in relation to time after registration for coronary artery bypass surgery: A population-based observational study","volume":"8","author":"Sobolev","year":"2013","journal-title":"J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ejcts\/ezx115","article-title":"Adverse events while awaiting myocardial revascularization: A systematic review and meta-analysis","volume":"52","author":"Head","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B54","first-page":"679","article-title":"Treating the right patient at the right time: Access to cardiac catheterization, percutaneous coronary intervention and cardiac surgery","volume":"22","author":"Graham","year":"2006","journal-title":"Can J Cardiol"},{"key":"2025110203570931700_ezy289-B55","first-page":"487","article-title":"Does ad hoc coronary intervention reduce radiation exposure? - Analysis of 568 patients","volume":"105","author":"Truffa","year":"2015","journal-title":"Arq Bras Cardiol"},{"key":"2025110203570931700_ezy289-B56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jcin.2009.01.006","article-title":"Predictors and outcomes of ad hoc versus non-ad hoc percutaneous coronary interventions","volume":"2","author":"Hannan","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(97)07298-X","article-title":"Coronary angioplasty versus medical therapy for angina: The second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants","volume":"350","author":"RITA-2 Trial Participants","year":"1997","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B58","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(01)06100-1","article-title":"Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): A randomised trial","volume":"358","author":"TIME","year":"2001","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B59","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B60","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.297.18.1985","article-title":"Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: The SWISSI II randomized controlled trial","volume":"297","author":"Erne","year":"2007","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B61","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"BARI Study Group 2D","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B62","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): A double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B64","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/eurheartj\/ehx796","article-title":"ORBITA revisited: what it really means and what it does not?","volume":"39","author":"Chaitman","year":"2018","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B65","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.jacc.2017.10.036","article-title":"Quality-of-life after everolimus-eluting stents or bypass surgery for left-main disease: Results from","volume":"70","author":"Baron","year":"2017","journal-title":"the EXCEL trial. J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B66","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.jacc.2017.02.031","article-title":"Quality of life after surgery or DES in patients with 3-vessel or left main disease","volume":"69","author":"Abdallah","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B67","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.2013.279208","article-title":"Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: A randomized clinical trial","volume":"310","author":"Abdallah","year":"2013","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B68","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","article-title":"Effect of coronary artery bypass graft surgery on survival: Overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration","volume":"344","author":"Yusuf","year":"1994","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B69","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1161\/CIRCULATIONAHA.112.000646","article-title":"Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease","volume":"127","author":"Bittl","year":"2013","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1067\/mhj.2001.116072","article-title":"Long-term survival in 11,661 patients with multivessel coronary artery disease in the era of stenting: A report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators","volume":"142","author":"Dzavik","year":"2001","journal-title":"Am Heart J"},{"key":"2025110203570931700_ezy289-B71","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jacc.2016.05.089","article-title":"Left main coronary artery disease: Secular trends in patient characteristics, treatments, and outcomes","volume":"68","author":"Lee","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B72","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.athoracsur.2006.04.044","article-title":"Selection of surgical or percutaneous coronary intervention provides differential longevity benefit","volume":"82","author":"Smith","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B73","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa071804","article-title":"Drug-eluting stents vs coronary-artery bypass grafting in multivessel coronary disease","volume":"358","author":"Hannan","year":"2008","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B74","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1161\/CIRCULATIONAHA.111.071811","article-title":"Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York","volume":"125","author":"Hannan","year":"2012","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B75","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/01.CIR.91.9.2335","article-title":"Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience","volume":"91","author":"Caracciolo","year":"1995","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B76","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.913111","article-title":"The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction","volume":"120","author":"Chaitman","year":"2009","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B77","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM198506273122603","article-title":"A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction","volume":"312","author":"Passamani","year":"1985","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B78","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B79","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0022-5223(96)70378-1","article-title":"Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease","volume":"111","author":"Jones","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B80","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jama.1994.03520190074038","article-title":"Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction","volume":"272","author":"Baker","year":"1994","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B81","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B82","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jacc.2014.04.064","article-title":"Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]","volume":"64","author":"Panza","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B83","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/CIRCULATIONAHA.116.024800","article-title":"Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: An analysis of the extended follow-up of the STICH trial (Surgical Treatment for Ischemic Heart Failure)","volume":"134","author":"Petrie","year":"2016","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B84","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehq500","article-title":"Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy","volume":"32","author":"Hachamovitch","year":"2011","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B85","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/01.CIR.95.8.2037","article-title":"Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: Outcomes of patients randomized to initial strategies of medical therapy versus revascularization","volume":"95","author":"Davies","year":"1997","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B86","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","article-title":"Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B87","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1161\/01.CIR.0000072790.23090.41","article-title":"Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography","volume":"107","author":"Hachamovitch","year":"2003","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B88","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.amjcard.2015.01.556","article-title":"Meta-analysis of trials on mortality after percutaneous coronary intervention compared with medical therapy in patients with stable coronary heart disease and objective evidence of myocardial ischemia","volume":"115","author":"Gada","year":"2015","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B89","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","article-title":"Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: A collaborative meta-analysis of contemporary randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025110203570931700_ezy289-B90","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jcin.2008.08.002","article-title":"Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease: a randomized, comparative, multicenter study","volume":"1","author":"Nishigaki","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B91","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.104.521864","article-title":"Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: A meta-analysis","volume":"111","author":"Katritsis","year":"2005","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B92","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jacc.2008.05.051","article-title":"A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease","volume":"52","author":"Schomig","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B93","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(09)60319-6","article-title":"Percutaneous coronary interventions for non-acute coronary artery disease: A quantitative 20-year synopsis and a network meta-analysis","volume":"373","author":"Trikalinos","year":"2009","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B94","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/CIRCULATIONAHA.112.131961","article-title":"Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease","volume":"127","author":"Bangalore","year":"2013","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B95","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCINTERVENTIONS.112.970954","article-title":"Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: A systematic review and meta-analysis of randomized clinical trials","volume":"5","author":"Pursnani","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B96","first-page":"472","article-title":"A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris","volume":"29","author":"Thomas","year":"2013","journal-title":"Can J Cardiol"},{"key":"2025110203570931700_ezy289-B97","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1408758","article-title":"Fractional flow reserve-guided PCI for stable coronary artery disease","volume":"371","author":"De Bruyne","year":"2014","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B98","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.321.7253.73","article-title":"Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: Meta-analysis of randomised controlled trials","volume":"321","author":"Bucher","year":"2000","journal-title":"BMJ"},{"key":"2025110203570931700_ezy289-B99","first-page":"312","article-title":"Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: Meta-analysis","volume":"172","author":"Stergiopoulos","year":"2012","journal-title":"of randomized controlled trials. Arch Intern Med"},{"key":"2025110203570931700_ezy289-B100","doi-asserted-by":"crossref","first-page":"g3859","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: Network meta-analysis","volume":"348","author":"Windecker","year":"2014","journal-title":"BMJ"},{"key":"2025110203570931700_ezy289-B101","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.amjmed.2008.07.027","article-title":"The impact of revascularization on mortality in patients with nonacute coronary artery disease","volume":"122","author":"Jeremias","year":"2009","journal-title":"Am J Med"},{"key":"2025110203570931700_ezy289-B102","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B103","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jacc.2010.09.038","article-title":"Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis","volume":"57","author":"Boudriot","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B104","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1100452","article-title":"Randomized trial of stents versus bypass surgery for left main coronary artery disease","volume":"364","author":"Park","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B105","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa1415447","article-title":"Trial of everolimus-eluting stents or bypass surgery for coronary disease","volume":"372","author":"Park","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B106","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/S0140-6736(16)32052-9","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial","volume":"388","author":"Makikallio","year":"2016","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B107","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","volume":"375","author":"Stone","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B108","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/ejcts\/ezs043","article-title":"EuroSCORE II","volume":"41","author":"Nashef","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B109","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.athoracsur.2009.05.053","article-title":"The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1\u2013coronary artery bypass grafting surgery","volume":"88","author":"Shahian","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B110","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.athoracsur.2009.05.055","article-title":"The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 3\u2013valve plus coronary artery bypass grafting surgery","volume":"88","author":"Shahian","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B111","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.athoracsur.2012.02.064","article-title":"Validation of EuroSCORE II in patients undergoing coronary artery bypass surgery","volume":"93","author":"Biancari","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B112","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/ejcts\/ezu033","article-title":"Performance of EuroSCORE II in a large US database: Implications for transcatheter aortic valve implantation","volume":"46","author":"Osnabrugge","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B113","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.amjcard.2016.08.024","article-title":"Meta-analysis comparing established risk prediction models (EuroSCORE II, STS Score, and ACEF Score) for perioperative mortality during cardiac surgery","volume":"118","author":"Sullivan","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B114","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/ejcts\/ezt122","article-title":"Comparison of the EuroSCORE II and Society of Thoracic Surgeons 2008 risk tools","volume":"44","author":"Kirmani","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-0034-1367734","article-title":"Clinical performance of the EuroSCORE II compared with the previous EuroSCORE iterations","volume":"62","author":"Velicki","year":"2014","journal-title":"Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B116","first-page":"219","article-title":"The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B117","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jacc.2010.03.044","article-title":"Value of the SYNTAX score for risk assessment in the all-comers population of the randomized multicenter LEADERS (Limus Eluted from A Durable versus ERodable Stent coating) trial","volume":"56","author":"Wykrzykowska","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B118","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jcin.2011.01.008","article-title":"The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial","volume":"4","author":"Garg","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B119","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.ijcard.2013.04.136","article-title":"Role of euroSCORE II in predicting long-term outcome after percutaneous catheter intervention for coronary triple vessel disease or left main stenosis","volume":"168","author":"Zhao","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203570931700_ezy289-B120","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/eurheartj\/ehx138","article-title":"Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: A pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials","volume":"38","author":"Cavalcante","year":"2017","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B121","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B122","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1161\/CIRCULATIONAHA.113.006689","article-title":"Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial","volume":"129","author":"Morice","year":"2014","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B123","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1093\/eurheartj\/ehu213","article-title":"Coronary artery bypass grafting vs percutaneous coronary intervention for patients with three-vessel disease: Final five-year follow-up of the SYNTAX trial","volume":"35","author":"Head","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B124","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: A pooled analysis of individual patient data","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B125","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jacc.2014.05.022","article-title":"Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: Insights from the SYNTAX trial","volume":"64","author":"Zhang","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1157\/13084649","article-title":"[A new classification of coronary bifurcation lesions]","volume":"59","author":"Medina","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"2025110203570931700_ezy289-B127","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","article-title":"Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: Development and validation of SYNTAX score II","volume":"381","author":"Farooq","year":"2013","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2015.03.248","article-title":"Validity of SYNTAX score II for risk stratification of percutaneous coronary interventions: A patient-level pooled analysis of 5,433 patients enrolled in contemporary coronary stent trials","volume":"187","author":"Campos","year":"2015","journal-title":"Int J Cardiol"},{"key":"2025110203570931700_ezy289-B129","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jcin.2016.04.023","article-title":"Individual long-term mortality prediction following either coronary stenting or bypass surgery in patients with multivessel and\/or unprotected left main disease: An external validation of the SYNTAX Score II model in the 1,480 patients of the BEST and PRECOMBAT randomized controlled trials","volume":"9","author":"Sotomi","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B130","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurheartj\/ehu518","article-title":"Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: Prospective validation of the SYNTAX Score II","volume":"36","author":"Campos","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B131","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jacc.2012.10.017","article-title":"The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: The SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial","volume":"61","author":"Farooq","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B132","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jacc.2013.05.033","article-title":"Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: A meta-analysis of 89,883 patients enrolled in randomized clinical trials and observational studies","volume":"62","author":"Garcia","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B133","first-page":"3","article-title":"Complete myocardial revascularization confers a larger clinical benefit when performed with state-of-the-art techniques in high-risk patients with multivessel coronary artery disease: A meta-analysis of randomized and observational studies","volume":"87","author":"Zimarino","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B134","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.113.001803","article-title":"Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score","volume":"128","author":"Farooq","year":"2013","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B135","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJMoa1412168","article-title":"Everolimus-eluting stents or bypass surgery for multivessel coronary disease","volume":"372","author":"Bangalore","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B136","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.jcin.2017.04.037","article-title":"Comparison of stenting versus bypass surgery according to the completeness of revascularization in severe coronary artery disease: Patient-level pooled analysis of the SYNTAX, PRECOMBAT, and BEST Trials","volume":"10","author":"Ahn","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B137","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurheartj\/ehu338","article-title":"Fractional flow reserve vs angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: The British Heart Foundation FAMOUS-NSTEMI randomized trial","volume":"36","author":"Layland","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B138","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.athoracsur.2016.01.105","article-title":"Comparison of EuroSCORE II, original EuroSCORE, and The Society of Thoracic Surgeons Risk Score in cardiac surgery patients","volume":"102","author":"Ad","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B139","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/bmj.39106.476215.BE","article-title":"Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery","volume":"334","author":"Aziz","year":"2007","journal-title":"BMJ"},{"key":"2025110203570931700_ezy289-B140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jcin.2008.07.001","article-title":"Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery","volume":"1","author":"Kapoor","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B141","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcin.2012.09.008","article-title":"Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 10-year follow-up of a randomized trial","volume":"6","author":"Blazek","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2014.09.074","article-title":"Coronary artery bypass graft surgery versus drug-eluting stents for patients with isolated proximal left anterior descending disease","volume":"64","author":"Hannan","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B143","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jcin.2014.08.006","article-title":"Comparison of sirolimus-eluting stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: 7-year follow-up of","volume":"8","author":"Blazek","year":"2015","journal-title":"a randomized trial. JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B144","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2009.03.032","article-title":"Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis","volume":"53","author":"Thiele","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B145","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jacc.2011.07.005","article-title":"Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: A meta-analysis of randomized clinical data","volume":"58","author":"Capodanno","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B146","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jacc.2015.03.033","article-title":"Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-Year outcomes of the PRECOMBAT study","volume":"65","author":"Ahn","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B147","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2016.06.024","article-title":"Outcomes after percutaneous coronary intervention or bypass surgery in patients with unprotected left main disease","volume":"68","author":"Cavalcante","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B148","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/jamacardio.2017.2895","article-title":"Percutaneous coronary intervention vs coronary artery bypass grafting in patients with left main coronary artery stenosis: A systematic review and meta-analysis","volume":"2","author":"Giacoppo","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2025110203570931700_ezy289-B149","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2016.04.034","article-title":"Long-term mortality after coronary revascularization in nondiabetic patients with multivessel disease","volume":"68","author":"Chang","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B150","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B151","doi-asserted-by":"crossref","first-page":"e002626","DOI":"10.1161\/CIRCINTERVENTIONS.115.002626","article-title":"Everolimus eluting stents versus coronary artery bypass graft surgery for patients with diabetes mellitus and multivessel disease","volume":"8","author":"Bangalore","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B152","doi-asserted-by":"crossref","first-page":"e000354","DOI":"10.1161\/JAHA.113.000354","article-title":"Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: Comprehensive systematic review and meta-analysis of randomized clinical data","volume":"2","author":"Hakeem","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2025110203570931700_ezy289-B153","doi-asserted-by":"crossref","first-page":"e010055","DOI":"10.1136\/bmjopen-2015-010055","article-title":"Has the difference in mortality between percutaneous coronary intervention and coronary artery bypass grafting in people with heart disease and diabetes changed over the years? A systematic review and meta-regression","volume":"5","author":"Herbison","year":"2015","journal-title":"BMJ Open"},{"key":"2025110203570931700_ezy289-B154","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jacc.2012.11.044","article-title":"Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes","volume":"61","author":"Kamalesh","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B155","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","article-title":"Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial","volume":"43","author":"Kappetein","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B156","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.10.014","article-title":"Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial","volume":"55","author":"Kapur","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B157","doi-asserted-by":"crossref","first-page":"e003255","DOI":"10.1161\/CIRCINTERVENTIONS.115.003255","article-title":"Impact of diabetic status on outcomes after revascularization with drug-eluting stents in relation to coronary artery disease complexity: Patient-level pooled analysis of 6081 patients","volume":"9","author":"Koskinas","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B158","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B159","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM200009283431303","article-title":"Multiple complex coronary plaques in patients with acute myocardial infarction","volume":"343","author":"Goldstein","year":"2000","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B160","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/j.jacc.2013.03.094","article-title":"A direct comparison of early and late outcomes with three approaches to carotid\u00e3 revascularization and open heart surgery","volume":"62","author":"Shishehbor","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B161","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jacc.2007.04.086","article-title":"Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: A pathologic study","volume":"50","author":"Cheruvu","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B162","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0735-1097(02)01770-9","article-title":"Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory","volume":"39","author":"Kerensky","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B163","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1056\/NEJMoa1109596","article-title":"Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction","volume":"365","author":"Kastrati","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B164","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1056\/NEJMoa0807986","article-title":"Early versus delayed invasive intervention in acute coronary syndromes","volume":"360","author":"Mehta","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B165","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1308075","article-title":"Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes","volume":"369","author":"Montalescot","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B166","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/eurheartj\/ehr418","article-title":"Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: The Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial)","volume":"33","author":"Thiele","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B167","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jacc.2011.06.046","article-title":"Conformational change in coronary artery structure assessed by optical coherence tomography in patients with vasospastic angina","volume":"58","author":"Tanaka","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B168","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ijcard.2011.09.032","article-title":"Presentations of acute coronary syndrome related to coronary lesion morphologies as assessed by intravascular ultrasound and optical coherence tomography","volume":"165","author":"Kato","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203570931700_ezy289-B169","doi-asserted-by":"crossref","first-page":"e2236","DOI":"10.4244\/EIJ-D-16-00187","article-title":"How and when to suspect spontaneous coronary artery dissection: Novel insights from a single-centre series on prevalence and angiographic appearance","volume":"12","author":"Motreff","year":"2017","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B170","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jacc.2006.06.050","article-title":"Benefit of early invasive therapy in acute coronary syndromes: A meta-analysis of contemporary randomized clinical trials","volume":"48","author":"Bavry","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B171","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","article-title":"Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data","volume":"55","author":"Fox","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B172","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","article-title":"Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: A randomised multicentre trial","volume":"385","author":"Valgimigli","year":"2015","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B173","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMoa1503943","article-title":"Polymer-free drug-coated coronary stents in patients at high bleeding risk","volume":"373","author":"Urban","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B174","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurheartj\/ehq276","article-title":"Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes","volume":"32","author":"Katritsis","year":"2011","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B175","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/0003-4819-158-4-201302190-00006","article-title":"Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: A systematic review and meta-analysis","volume":"158","author":"Navarese","year":"2013","journal-title":"Ann Intern Med"},{"key":"2025110203570931700_ezy289-B176","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(17)31490-3","article-title":"Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: A meta-analysis of randomised trials","volume":"390","author":"Jobs","year":"2017","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B177","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jama.2012.10065","article-title":"Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: The COMFORTABLE AMI randomized trial","volume":"308","author":"Raber","year":"2012","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B178","first-page":"55","article-title":"Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials","volume":"7","author":"Sabate","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B179","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jcin.2013.09.008","article-title":"Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: A pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY)","volume":"7","author":"Valgimigli","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B180","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2014.05.064","article-title":"Effect of aspiration thrombectomy on microvascular obstruction in NSTEMI patients: The TATORT-NSTEMI trial","volume":"64","author":"Thiele","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B181","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jacc.2016.06.035","article-title":"Long-term prognosis of deferred acute coronary syndrome lesions based on nonischemic fractional flow reserve","volume":"68","author":"Hakeem","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B182","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(00)02427-2","article-title":"Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease","volume":"3","author":"Wallentin","year":"2000","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B183","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)\u2013Thrombolysis in Myocardial Infarction 18 Investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B184","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCINTERVENTIONS.111.961862","article-title":"SYNTAX score reproducibility and variability between interventional cardiologists, core laboratory technicians, and quantitative coronary measurements","volume":"4","author":"Genereux","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B185","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jacc.2015.10.082","article-title":"Single-staged compared with multi-staged PCI in multivessel NSTEMI patients:","volume":"67","author":"Sardella","year":"2016","journal-title":"The SMILE Trial. J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B186","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1109719","article-title":"Thrombin-receptor antagonist vorapaxar in acute coronary syndromes","volume":"366","author":"Tricoci","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B187","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/eurheartj\/ehu160","article-title":"Ticagrelor vs clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: Results from the PLATO trial","volume":"35","author":"Lindholm","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B188","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jacc.2009.04.076","article-title":"All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients","volume":"54","author":"Curtis","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B189","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/1756-0500-5-342","article-title":"Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: A retrospective analysis","volume":"5","author":"Meadows","year":"2012","journal-title":"BMC Res Notes"},{"key":"2025110203570931700_ezy289-B190","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B191","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.amjcard.2011.04.005","article-title":"Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007","volume":"108","author":"Ranasinghe","year":"2011","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B192","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jtcvs.2012.05.043","article-title":"Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris","volume":"145","author":"Fukui","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B193","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/bja\/aew189","article-title":"Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: A prospective observational study","volume":"117","author":"Malm","year":"2016","journal-title":"Br J Anaesth"},{"key":"2025110203570931700_ezy289-B194","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.amjcard.2017.04.038","article-title":"Comparison of outcome of coronary artery bypass grafting versus drug-eluting stent implantation for non-ST-elevation acute coronary syndrome","volume":"120","author":"Chang","year":"2017","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B195","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jacc.2011.02.032","article-title":"Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial","volume":"57","author":"Palmerini","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B196","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1016\/j.jacc.2017.10.029","article-title":"Surgical versus percutaneous coronary revascularization in patients with diabetes and acute coronary syndromes","volume":"70","author":"Ramanathan","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B197","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2015.10.006","article-title":"Trends in coronary angiography, revascularization, and outcomes of cardiogenic shock complicating non-ST-elevation myocardial infarction","volume":"117","author":"Kolte","year":"2016","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B198","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B199","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehy004","article-title":"Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: Results from the German prospective, multicentre FITT-STEMI trial","volume":"39","author":"Scholz","year":"2018","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B200","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(06)68148-8","article-title":"Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: Quantitative review of randomised trials","volume":"367","author":"Keeley","year":"2006","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B201","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/eurheartj\/ehi810","article-title":"Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients","volume":"27","author":"Boersma","year":"2006","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B202","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1001\/jama.283.20.2686","article-title":"Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis","volume":"283","author":"Morrison","year":"2000","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B203","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(02)09963-4","article-title":"Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: A randomised study","volume":"360","author":"Bonnefoy","year":"2002","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B204","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehp156","article-title":"Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up","volume":"30","author":"Bonnefoy","year":"2009","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B205","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.111.018549","article-title":"Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase","volume":"124","author":"Pinto","year":"2011","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B206","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","article-title":"Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction","volume":"368","author":"Armstrong","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B207","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2014.15095","article-title":"Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction","volume":"312","author":"Park","year":"2014","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B208","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacc.2011.02.071","article-title":"Prognostic impact of staged versus \"one-time\" multivessel percutaneous intervention in acute myocardial infarction: Analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial","volume":"58","author":"Kornowski","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B209","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/hrt.2009.177162","article-title":"A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: Major adverse cardiac events during long-term follow-up","volume":"96","author":"Politi","year":"2010","journal-title":"Heart"},{"key":"2025110203570931700_ezy289-B210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/14628840310030441","article-title":"Single vs multivessel treatment during primary angioplasty: Results of the multicentre randomised HEpacoat for cuLPrit or multivessel stenting for Acute Myocardial Infarction (HELP AMI) Study","volume":"6","author":"Di Mario","year":"2004","journal-title":"Int J Cardiovasc Intervent"},{"key":"2025110203570931700_ezy289-B211","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","article-title":"Randomized trial of preventive angioplasty in myocardial infarction","volume":"369","author":"Wald","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B212","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","article-title":"Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: The CvLPRIT trial","volume":"65","author":"Gershlick","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B213","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): An open-label, randomised controlled trial","volume":"386","author":"Engstrom","year":"2015","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B214","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","article-title":"Fractional flow reserve-guided multivessel angioplasty in myocardial infarction","volume":"376","author":"Smits","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jcin.2016.11.047","article-title":"Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: A pairwise and network meta-analysis of randomized trials","volume":"10","author":"Elgendy","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B216","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehm402","article-title":"Meta-analysis of randomized trials on drug-eluting stents vs bare-metal stents in patients with acute myocardial infarction","volume":"28","author":"Kastrati","year":"2007","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B217","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","article-title":"Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial","volume":"380","author":"Sabate","year":"2012","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B218","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(15)00548-6","article-title":"Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial","volume":"387","author":"Sabate","year":"2016","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B219","doi-asserted-by":"crossref","first-page":"e003388","DOI":"10.1161\/CIRCINTERVENTIONS.115.003388","article-title":"Comparison of immediate with delayed stenting using the Minimalist Immediate Mechanical Intervention approach in acute ST-segment-elevation myocardial infarction: The MIMI study","volume":"9","author":"Belle","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B220","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2014.02.530","article-title":"A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI)","volume":"63","author":"Carrick","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B221","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(16)30072-1","article-title":"Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): An open-label, randomised controlled trial","volume":"387","author":"Kelbaek","year":"2016","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B222","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijcard.2011.11.102","article-title":"A meta-analytic overview of thrombectomy during primary angioplasty","volume":"166","author":"De Luca","year":"2013","journal-title":"Int J Cardiol"},{"key":"2025110203570931700_ezy289-B223","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1308789","article-title":"Thrombus aspiration during ST-segment elevation myocardial infarction","volume":"369","author":"Frobert","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B224","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1405707","article-title":"Outcomes 1 year after thrombus aspiration for myocardial infarction","volume":"371","author":"Lagerqvist","year":"2014","journal-title":"N Engl J Med"},{"issue":"15","key":"2025110203570931700_ezy289-B225","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJMoa1415098","article-title":"Randomized trial of primary PCI with or without routine manual thrombectomy","volume":"372","author":"Jolly","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B226","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0140-6736(15)00448-1","article-title":"Outcomes after thrombus aspiration for ST elevation myocardial infarction: 1-year follow-up of the prospective randomised TOTAL trial","volume":"387","author":"Jolly","year":"2016","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B227","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1093\/eurheartj\/ehv296","article-title":"Stroke in the TOTAL trial: A randomized trial of routine thrombectomy vs percutaneous coronary intervention alone in ST elevation myocardial infarction","volume":"36","author":"Jolly","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"2025110203570931700_ezy289-B228","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCULATIONAHA.116.025371","article-title":"Thrombus aspiration in ST-segment-elevation myocardial infarction: An individual patient meta-analysis: Thrombectomy Trialists Collaboration","volume":"135","author":"Jolly","year":"2017","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B229","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jacc.2009.08.007","article-title":"Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction)","volume":"55","author":"Bohmer","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B230","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMoa0808276","article-title":"Routine early angioplasty after fibrinolysis for acute myocardial infarction","volume":"360","author":"Cantor","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B231","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(08)60268-8","article-title":"Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): An open, prospective, randomised, multicentre trial","volume":"371","author":"Di Mario","year":"2008","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B232","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMoa050849","article-title":"Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction","volume":"353","author":"Gershlick","year":"2005","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B233","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1001\/jama.293.23.2865","article-title":"Beyond 12 hours Reperfusion AlternatiVe Evaluation Trial Investigators. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: A randomized controlled trial","volume":"293","author":"Schomig","year":"2005","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B234","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/eurheartj\/ehp113","article-title":"Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs 12-72 h","volume":"30","author":"Busk","year":"2009","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B235","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa066139","article-title":"Coronary intervention for persistent occlusion after myocardial infarction","volume":"355","author":"Hochman","year":"2006","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B236","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(96)02514-7","article-title":"Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour","volume":"348","author":"Boersma","year":"1996","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B237","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa025142","article-title":"A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction","volume":"349","author":"Andersen","year":"2003","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B238","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.CIR.0000091088.63921.8C","article-title":"Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: A meta-analysis","volume":"108","author":"Dalby","year":"2003","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B239","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.108.818617","article-title":"Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: A randomized double-blind trial","volume":"119","author":"Mehilli","year":"2009","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B240","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1161\/CIRCULATIONAHA.105.586198","article-title":"Implementation of guidelines improves the standard of care: The Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry)","volume":"113","author":"Kalla","year":"2006","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B241","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/CIRCULATIONAHA.107.694141","article-title":"A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"116","author":"Henry","year":"2007","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B242","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1161\/CIRCULATIONAHA.107.184052","article-title":"Development of systems of care for ST-elevation myocardial infarction patients: gap, barriers, and implications","volume":"116","author":"Nallamothu","year":"2007","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B243","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurheartj\/ehp492","article-title":"Reperfusion therapy for ST elevation acute myocardial infarction in Europe: Description of the current situation in 30 countries","volume":"31","author":"Widimsky","year":"2010","journal-title":"Eur Heart J"},{"issue":"299","key":"2025110203570931700_ezy289-B244","first-page":"301","article-title":"How to set up an effective national primary angioplasty network: lessons learned from five European countries","volume":"5","author":"Knot","year":"2009","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B245","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1056\/NEJMsa063117","article-title":"Strategies for reducing the door-to-balloon time in acute myocardial infarction","volume":"355","author":"Bradley","year":"2006","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B246","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1161\/CIRCULATIONAHA.106.638353","article-title":"Hospital delays in reperfusion for ST-elevation myocardial infarction: Implications when selecting a reperfusion strategy","volume":"114","author":"Pinto","year":"2006","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B247","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1136\/hrt.2006.101972","article-title":"Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: The USIC 2000 registry","volume":"92","author":"Steg","year":"2006","journal-title":"Heart"},{"key":"2025110203570931700_ezy289-B248","doi-asserted-by":"crossref","first-page":"e003255","DOI":"10.1161\/CIRCHEARTFAILURE.116.003255","article-title":"Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease: A meta-analysis","volume":"10","author":"Wolff","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2025110203570931700_ezy289-B249","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.114.014932","article-title":"Influence of baseline characteristics, operative conduct, and postoperative course on 30-day outcomes of coronary artery bypass grafting among patients with left ventricular dysfunction: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Trial","volume":"132","author":"Wrobel","year":"2015","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B250","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.115.021168","article-title":"Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: Everolimus-eluting stents versus coronary artery bypass graft surgery","volume":"133","author":"Bangalore","year":"2016","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B251","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jacc.2017.12.024","article-title":"Coronary artery bypass surgery improves outcomes in patients with diabetes and left ventricular dysfunction","volume":"71","author":"Nagendran","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B252","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa0900559","article-title":"Coronary bypass surgery with or without surgical ventricular reconstruction","volume":"360","author":"Jones","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B253","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/eurheartj\/ehs021","article-title":"Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy","volume":"34","author":"Oh","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B254","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jtcvs.2010.10.026","article-title":"Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatments for Ischemic Heart Failure (STICH) trial","volume":"141","author":"Dor","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B255","first-page":"V102","article-title":"Coronary artery surgery study (CASS): A randomized trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction","volume":"72","author":"Killip","year":"1985","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B256","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/eurjhf\/hfq020","article-title":"End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy","volume":"12","author":"Di Donato","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2025110203570931700_ezy289-B257","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jtcvs.2012.09.007","article-title":"Insights from the STICH trial: Change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction","volume":"146","author":"Michler","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B258","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock","volume":"341","author":"Hochman","year":"1999","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B259","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/CIRCULATIONAHA.105.540948","article-title":"Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: Results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B260","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","article-title":"Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): Final 12 month results of a randomised, open-label trial","volume":"382","author":"Thiele","year":"2013","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B261","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B262","first-page":"CD007398","article-title":"Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock","volume":"3","author":"Unverzagt","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203570931700_ezy289-B263","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1007\/s00134-016-4536-8","article-title":"Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis","volume":"42","author":"Ouweneel","year":"2016","journal-title":"Intensive Care Med"},{"key":"2025110203570931700_ezy289-B264","doi-asserted-by":"crossref","first-page":"469.e1","DOI":"10.1016\/j.ahj.2006.05.031","article-title":"A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock","volume":"152","author":"Burkhoff","year":"2006","journal-title":"Am Heart J"},{"key":"2025110203570931700_ezy289-B265","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","article-title":"A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction","volume":"52","author":"Seyfarth","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B266","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/eurheartj\/ehx363","article-title":"Percutaneous short-term active mechanical support devices in cardiogenic shock: A systematic review and collaborative meta-analysis of randomized trials","volume":"38","author":"Thiele","year":"2017","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B267","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/CIRCULATIONAHA.112.098194","article-title":"A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: The PROTECT II study","volume":"126","author":"O'Neill","year":"2012","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B268","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/j.jacc.2016.02.025","article-title":"Ventricular assist device in acute myocardial infarction","volume":"67","author":"Acharya","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B269","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","article-title":"Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction","volume":"295","author":"Hochman","year":"2006","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B270","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0735-1097(00)00732-4","article-title":"Management of coronary artery disease: Therapeutic options in patients with diabetes","volume":"36","author":"Hammoud","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B271","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B272","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/01.CIR.0000089189.70578.E2","article-title":"Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part II","volume":"108","author":"Luscher","year":"2003","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B273","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0735-1097(01)01183-4","article-title":"New diagnostic criteria for diabetes and coronary artery disease: Insights from an angiographic study","volume":"37","author":"Ledru","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B274","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/01.CIR.102.18.2180","article-title":"Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus","volume":"102","author":"Moreno","year":"2000","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B275","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.jcmg.2012.01.008","article-title":"Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes","volume":"5","author":"Marso","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"key":"2025110203570931700_ezy289-B276","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.92.7.1731","article-title":"Unstable angina. A comparison of angioscopic findings between diabetic and nondiabetic patients","volume":"92","author":"Silva","year":"1995","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B277","first-page":"106","article-title":"An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes:","volume":"60","author":"O'Donoghue","year":"2012","journal-title":"A collaborative meta-analysis of randomized trials. J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B278","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCINTERVENTIONS.111.963512","article-title":"Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D)","volume":"5","author":"Schwartz","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B279","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2014.06.1182","article-title":"Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: Results from","volume":"64","author":"Dangas","year":"2014","journal-title":"the FREEDOM trial. J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1148\/radiol.09090690","article-title":"Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin","volume":"254","author":"Goergen","year":"2010","journal-title":"Radiology"},{"key":"2025110203570931700_ezy289-B281","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4244\/EIJ-D-17-00620","article-title":"The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: Five-year follow-up of the SYNTAX trial","volume":"14","author":"Milojevic","year":"2018","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B282","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B283","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jacc.2013.03.086","article-title":"Impact of periprocedural bleeding on incidence of contrast-induced acute kidney injury in patients treated with percutaneous coronary intervention","volume":"62","author":"Ohno","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B284","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxic effects in high-risk patients undergoing angiography","volume":"348","author":"Aspelin","year":"2003","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B285","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jacc.2006.06.047","article-title":"Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: The RECOVER study: A randomized controlled trial","volume":"48","author":"Jo","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B286","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1161\/CIRCULATIONAHA.106.671644","article-title":"Cardiac Angiography in Renally Impaired Patients (CARE) study: A randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease","volume":"115","author":"Solomon","year":"2007","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B287","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7326\/0003-4819-150-3-200902030-00006","article-title":"Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality","volume":"150","author":"Marenzi","year":"2009","journal-title":"Ann Intern Med"},{"key":"2025110203570931700_ezy289-B288","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jacc.2007.03.058","article-title":"Volume-to-creatinine clearance ratio: A pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention","volume":"50","author":"Laskey","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B289","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archinte.162.3.329","article-title":"Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty","volume":"162","author":"Mueller","year":"2002","journal-title":"Arch Intern Med"},{"key":"2025110203570931700_ezy289-B290","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","article-title":"Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial","volume":"291","author":"Merten","year":"2004","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B291","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jama.300.9.1038","article-title":"Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: A randomized trial","volume":"300","author":"Brar","year":"2008","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B292","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(17)30057-0","article-title":"Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): A prospective, randomised, phase 3, controlled, open-label, non-inferiority trial","volume":"389","author":"Nijssen","year":"2017","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B293","doi-asserted-by":"crossref","first-page":"e004383","DOI":"10.1161\/CIRCINTERVENTIONS.116.004383","article-title":"Preventive strategies for contrast-induced acute kidney injury in patients undergoing percutaneous coronary procedures: Evidence from a hierarchical Bayesian network meta-analysis of 124 trials and 28\u2009240 patients","volume":"10","author":"Giacoppo","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B294","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B295","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcin.2015.09.026","article-title":"Prevention of contrast-induced nephropathy by central venous pressure-guided fluid administration in chronic kidney disease and congestive heart failure patients","volume":"9","author":"Qian","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B296","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.111.030759","article-title":"Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury","volume":"124","author":"Briguori","year":"2011","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B297","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcin.2016.11.006","article-title":"Prevention of contrast-induced acute kidney injury by furosemide with matched hydration in patients undergoing interventional procedures: A systematic review and meta-analysis of randomized trials","volume":"10","author":"Putzu","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B298","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa023204","article-title":"The prevention of radiocontrast-agent-induced nephropathy by hemofiltration","volume":"349","author":"Marenzi","year":"2003","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B299","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2005.08.002","article-title":"Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients","volume":"119","author":"Marenzi","year":"2006","journal-title":"Am J Med"},{"key":"2025110203570931700_ezy289-B300","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjmed.2011.06.029","article-title":"Renal replacement therapies for prevention of radiocontrast-induced nephropathy: A systematic review","volume":"125","author":"Cruz","year":"2012","journal-title":"Am J Med"},{"key":"2025110203570931700_ezy289-B301","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0002-9343(01)00983-4","article-title":"Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful","volume":"111","author":"Vogt","year":"2001","journal-title":"Am J Med"},{"key":"2025110203570931700_ezy289-B302","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2017.05.117","article-title":"Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio","volume":"243","author":"Scarsini","year":"2017","journal-title":"Int J Cardiol"},{"key":"2025110203570931700_ezy289-B303","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.4244\/EIJ-D-17-00542","article-title":"Physiologic evaluation of coronary lesions using instantaneous wave-free ratio (iFR) in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation","volume":"13","author":"Scarsini","year":"2018","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B304","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.amjcard.2017.03.250","article-title":"Correlation between angiographic and physiologic evaluation of coronary artery narrowings in patients with aortic valve stenosis","volume":"120","author":"Di Gioia","year":"2017","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B305","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ejcts\/ezx324","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"52","author":"Falk","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B306","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jjcc.2016.10.007","article-title":"Long-term outcome of isolated off-pump coronary artery bypass grafting in patients with coronary artery disease and mild to moderate aortic stenosis","volume":"70","author":"Yamashita","year":"2017","journal-title":"J Cardiol"},{"key":"2025110203570931700_ezy289-B307","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMoa1512913","article-title":"Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation","volume":"374","author":"Goldstein","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B308","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1410490","article-title":"Surgical treatment of moderate ischemic mitral regurgitation","volume":"371","author":"Smith","year":"2014","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B309","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMoa1602003","article-title":"Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation","volume":"374","author":"Michler","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B310","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1161\/CIRCULATIONAHA.112.143818","article-title":"RIME Investigators Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial","volume":"126","author":"Chan","year":"2012","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B311","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ehjci\/jet105","article-title":"Recommendations for the echocardiographic assessment of native valvular regurgitation: An executive summary from the European Association of Cardiovascular Imaging","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025110203570931700_ezy289-B312","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"2025110203570931700_ezy289-B313","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacc.2018.04.071","article-title":"Stroke rates following surgical versus percutaneous coronary revascularization","volume":"72","author":"Head","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B314","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejvs.2011.02.016","article-title":"Stroke after cardiac surgery and its association with asymptomatic carotid disease: An updated systematic review and meta-analysis","volume":"41","author":"Naylor","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2025110203570931700_ezy289-B315","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jtcvs.2015.02.003","article-title":"Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting?","volume":"149","author":"Masabni","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B316","first-page":"71","article-title":"Does the risk of post-CABG stroke merit staged or synchronous reconstruction in patients with symptomatic or asymptomatic carotid disease?","volume":"50","author":"Naylor","year":"2009","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"2025110203570931700_ezy289-B317","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: The European Stroke Organization (ESO). The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B318","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.athoracsur.2007.03.025","article-title":"Preoperative noncontrast chest computed tomography identifies potential aortic emboli","volume":"84","author":"Lee","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B319","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/ejvs.2002.1895","article-title":"A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass","volume":"25","author":"Naylor","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2025110203570931700_ezy289-B320","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejvs.2016.12.019","article-title":"Carotid stenting prior to coronary bypass surgery: An updated systematic review and meta-analysis","volume":"53","author":"Paraskevas","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2025110203570931700_ezy289-B321","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jvs.2015.10.008","article-title":"Clinical utility of carotid duplex ultrasound prior to cardiac surgery","volume":"63","author":"Lin","year":"2016","journal-title":"J Vasc Surg"},{"key":"2025110203570931700_ezy289-B322","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.lpm.2009.02.015","article-title":"Indications for carotid screening in patients with coronary artery disease","volume":"38","author":"Aboyans","year":"2009","journal-title":"Presse Med"},{"key":"2025110203570931700_ezy289-B323","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jacc.2008.10.011","article-title":"Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory\/operating room","volume":"53","author":"Zhao","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B324","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejcts.2006.03.062","article-title":"Emergency re-revascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery","volume":"30","author":"Thielmann","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B325","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B326","doi-asserted-by":"crossref","first-page":"S226","DOI":"10.1161\/CIRCULATIONAHA.112.000347","article-title":"Impact of expeditious management of perioperative myocardial ischemia in patients undergoing isolated coronary artery bypass surgery","volume":"128","author":"Davierwala","year":"2013","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B327","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/icvts\/ivr127","article-title":"Management of early postoperative coronary artery bypass graft failure","volume":"14","author":"Laflamme","year":"2012","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203570931700_ezy289-B328","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.athoracsur.2014.12.063","article-title":"Results of emergency postoperative re-angiography after cardiac surgery procedures","volume":"99","author":"Gaudino","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B329","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/eurheartj\/ehx383","article-title":"ESC Joint Working Groups on Cardiovascular Surgery and the Cellular Biology of the Heart Position Paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery","volume":"38","author":"Thielmann","year":"2017","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B330","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1161\/01.CIR.0000036595.92742.69","article-title":"Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era","volume":"106","author":"Seshadri","year":"2002","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B331","first-page":"131","article-title":"Failed percutaneous coronary intervention: A decade of experience in 21,000 patients","volume":"71","author":"Mattichak","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B332","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.021092","article-title":"Temporal trends in predictors of early and late mortality after emergency coronary artery bypass grafting for cardiogenic shock complicating acute myocardial infarction","volume":"134","author":"Davierwala","year":"2016","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B333","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/ejcts\/ezv388","article-title":"Is emergency and salvage coronary artery bypass grafting justified? The Nordic Emergency\/Salvage coronary artery bypass grafting study","volume":"49","author":"Axelsson","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B334","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jcin.2016.09.044","article-title":"Incidence, characteristics, predictors, and outcomes of repeat revascularization after percutaneous coronary intervention and coronary artery bypass grafting: The SYNTAX trial at 5 years","volume":"9","author":"Parasca","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B335","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/heartjnl-2013-304933","article-title":"Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography","volume":"100","author":"Cassese","year":"2014","journal-title":"Heart"},{"key":"2025110203570931700_ezy289-B336","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","article-title":"Risk of stent thrombosis among bare-metal stents first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients","volume":"6","author":"Tada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B337","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.athoracsur.2005.04.033","article-title":"Is reoperation still a risk factor in coronary artery bypass surgery?","volume":"80","author":"Sabik","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B338","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.athoracsur.2009.02.006","article-title":"Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality","volume":"87","author":"Yap","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B339","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/CIRCULATIONAHA.113.001882","article-title":"Repeat coronary revascularization after coronary artery bypass surgery in older adults: The Society of Thoracic Surgeons' national experience, 1991-2007","volume":"127","author":"Fosbol","year":"2013","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B340","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/eurheartj\/ehi646","article-title":"Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery","volume":"27","author":"Brener","year":"2006","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B341","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0735-1097(02)02560-3","article-title":"Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients","volume":"40","author":"Morrison","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B342","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0735-1097(01)01366-3","article-title":"Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME)","volume":"38","author":"Morrison","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B343","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2459\/JCM.0b013e328356a4fc","article-title":"Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure","volume":"14","author":"Harskamp","year":"2013","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2025110203570931700_ezy289-B344","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jacc.2012.09.045","article-title":"Value of internal thoracic artery grafting to the left anterior descending coronary artery at coronary reoperation","volume":"61","author":"Sabik","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B345","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/icvts\/ivv338","article-title":"Reusing the patent internal mammary artery as a conduit in redo coronary artery bypass surgery","volume":"22","author":"Nwaejike","year":"2016","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203570931700_ezy289-B346","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.106.651232","article-title":"Saphenous vein graft stenting and major adverse cardiac events: A predictive model derived from a pooled analysis of 3958 patients","volume":"117","author":"Coolong","year":"2008","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B347","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.0000012783.63093.0C","article-title":"Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts","volume":"105","author":"Baim","year":"2002","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B348","doi-asserted-by":"crossref","first-page":"e005538","DOI":"10.1161\/CIRCINTERVENTIONS.117.005538","article-title":"Outcomes of saphenous vein graft intervention with and without embolic protection device: A comprehensive review and meta-analysis","volume":"10","author":"Paul","year":"2017","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B349","doi-asserted-by":"crossref","first-page":"e001403","DOI":"10.1161\/CIRCINTERVENTIONS.114.001403","article-title":"Jr. Three-year outcomes associated with embolic protection in saphenous vein graft intervention: Results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry","volume":"8","author":"Brennan","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B350","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/01.CIR.0000080894.51311.0A","article-title":"Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts","volume":"108","author":"Stone","year":"2003","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B351","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jacc.2007.06.039","article-title":"The PROXIMAL trial: Proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: A randomized, prospective, multicenter clinical trial","volume":"50","author":"Mauri","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B352","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/S0735-1097(03)01038-6","article-title":"A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts","volume":"42","author":"Sch\u00e4chinger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B353","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.0000079106.71097.1C","article-title":"Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial","volume":"108","author":"Stankovic","year":"2003","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B354","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(11)61255-5","article-title":"Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): A randomised controlled superiority trial","volume":"378","author":"Mehilli","year":"2011","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B355","first-page":"919","article-title":"A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions","volume":"53","author":"Brilakis","year":"2009","journal-title":"the SOS (Stenting of Saphenous Vein Grafts) trial. J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B356","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.jacc.2006.09.021","article-title":"Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: Six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial","volume":"48","author":"Vermeersch","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B357","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2018.03.456","article-title":"Efficacy over time with drug-eluting stents in saphenous vein graft lesions","volume":"71","author":"Colleran","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B358","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcin.2010.10.003","article-title":"Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial","volume":"4","author":"Brilakis","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B359","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jacc.2007.05.010","article-title":"Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: Results from the randomized DELAYED RRISC Trial","volume":"50","author":"Vermeersch","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B360","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2010.02.009","article-title":"Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: The ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study","volume":"55","author":"Mehilli","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B361","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.293.2.165","article-title":"Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial","volume":"293","author":"Kastrati","year":"2005","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B362","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.jacc.2005.10.078","article-title":"A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: Results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial","volume":"47","author":"Alfonso","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B363","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0735-1097(03)00852-0","article-title":"A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis","volume":"42","author":"Alfonso","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B364","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jacc.2006.10.049","article-title":"Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: Meta-analysis of randomized trials","volume":"49","author":"Dibra","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B365","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcin.2012.01.008","article-title":"Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"5","author":"Scheller","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B366","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa061254","article-title":"Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"355","author":"Scheller","year":"2006","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B367","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ahj.2013.07.002","article-title":"A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis","volume":"166","author":"Habara","year":"2013","journal-title":"Am Heart J"},{"key":"2025110203570931700_ezy289-B368","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis","volume":"119","author":"Unverdorben","year":"2009","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B369","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: The PEPCAD-DES study","volume":"59","author":"Rittger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B370","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcin.2010.10.012","article-title":"Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis","volume":"4","author":"Habara","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B371","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, , paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): A randomised, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B372","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/heartjnl-2012-302945","article-title":"Drug-eluting balloon angioplasty for in-stent restenosis: A systematic review and meta-analysis of randomised controlled trials","volume":"99","author":"Indermuehle","year":"2013","journal-title":"Heart"},{"key":"2025110203570931700_ezy289-B373","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2013.12.006","article-title":"A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: The RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting balloon vs everolimus-eluting stent)","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B374","doi-asserted-by":"crossref","first-page":"e003316","DOI":"10.1161\/CIRCINTERVENTIONS.115.003316","article-title":"Comparison of the efficacy of paclitaxel-eluting balloon catheters and everolimus-eluting stents in the treatment of coronary in-stent restenosis: the treatment of in-stent restenosis study","volume":"9","author":"Pleva","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B375","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: The RIBS IV randomized clinical trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B376","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: The DARE trial","volume":"11","author":"Baan","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B377","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2017.04.024","article-title":"Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents:","volume":"10","author":"Kufner","year":"2017","journal-title":"A randomized controlled trial. JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B378","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0140-6736(15)60657-2","article-title":"Percutaneous coronary interventional strategies for treatment of in-stent restenosis: A network meta-analysis","volume":"386","author":"Siontis","year":"2015","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B379","doi-asserted-by":"crossref","first-page":"h5392","DOI":"10.1136\/bmj.h5392","article-title":"Treatment strategies for coronary in-stent restenosis: Systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients","volume":"351","author":"Giacoppo","year":"2015","journal-title":"BMJ"},{"key":"2025110203570931700_ezy289-B380","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcin.2015.01.031","article-title":"Long-term efficacy and safety of paclitaxel-eluting balloon for the treatment of drug-eluting stent restenosis: 3-year results of","volume":"8","author":"Kufner","year":"2015","journal-title":"a randomized controlled trial. JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B381","first-page":"624","article-title":"Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis","volume":"87","author":"Xu","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B382","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4244\/EIJV9I7A132","article-title":"Differential relative efficacy between drug-eluting stents in patients with bare metal and drug-eluting stent restenosis; Evidence in support of drug resistance: Insights from the ISAR-DESIRE and ISAR-DESIRE 2 trials","volume":"9","author":"Byrne","year":"2013","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B383","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacc.2011.11.024","article-title":"Coronary artery disease progression late after successful stent implantation","volume":"59","author":"Zellweger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B384","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B385","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.jacc.2008.01.070","article-title":"ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients","volume":"51","author":"Chechi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B386","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/heartjnl-2012-302183","article-title":"Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis","volume":"98","author":"Alfonso","year":"2012","journal-title":"Heart"},{"key":"2025110203570931700_ezy289-B387","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/CIRCULATIONAHA.117.026788","article-title":"Optical coherence tomography findings in patients with coronary stent thrombosis: A report of the PRESTIGE Consortium review","volume":"136","author":"Adriaenssens","year":"2017","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B388","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcin.2011.10.013","article-title":"Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis","volume":"5","author":"Armstrong","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B389","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/01.CIR.73.6.1254","article-title":"The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: A report from the Coronary Artery Surgery Study","volume":"73","author":"Holmes","year":"1986","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B390","first-page":"1173","article-title":"European Coronary Surgery Study Group","volume":"2","author":"Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris","year":"1982","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B391","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1161\/hc3801.096335","article-title":"Prior coronary artery bypass surgery and risk of death among patients with ischemic left ventricular dysfunction","volume":"104","author":"Veenhuyzen","year":"2001","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B392","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B393","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1540-8167.2008.01191.x","article-title":"Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)","volume":"19","author":"Al-Khatib","year":"2008","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025110203570931700_ezy289-B394","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.hrthm.2007.07.013","article-title":"Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: A MADIT-II substudy","volume":"4","author":"Sesselberg","year":"2007","journal-title":"Heart Rhythm"},{"key":"2025110203570931700_ezy289-B395","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJM199706053362302","article-title":"Immediate coronary angiography in survivors of out-of-hospital cardiac arrest","volume":"336","author":"Spaulding","year":"1997","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B396","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jcin.2012.01.017","article-title":"Optimal treatment of patients surviving out-of-hospital cardiac arrest","volume":"5","author":"Kern","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B397","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.106.657619","article-title":"Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction","volume":"115","author":"Garot","year":"2007","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B398","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.amjcard.2011.04.008","article-title":"Angiographic characteristics of coronary disease and postresuscitation electrocardiograms in patients with aborted cardiac arrest outside a hospital","volume":"108","author":"Radsel","year":"2011","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B399","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ahj.2008.09.016","article-title":"Acute coronary angiographic findings in survivors of out-of-hospital cardiac arrest","volume":"157","author":"Anyfantakis","year":"2009","journal-title":"Am Heart J"},{"key":"2025110203570931700_ezy289-B400","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCINTERVENTIONS.109.913665","article-title":"Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: Insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry","volume":"3","author":"Dumas","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B401","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/cc10227","article-title":"Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation","volume":"15","author":"Cronier","year":"2011","journal-title":"Crit Care"},{"key":"2025110203570931700_ezy289-B402","doi-asserted-by":"crossref","first-page":"e002303","DOI":"10.1161\/CIRCINTERVENTIONS.114.002303","article-title":"Immediate percutaneous coronary intervention is associated with improved short- and long-term survival after out-of-hospital cardiac arrest","volume":"8","author":"Geri","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B403","doi-asserted-by":"crossref","first-page":"e002321","DOI":"10.1161\/CIRCINTERVENTIONS.114.002321","article-title":"Early coronary angiography and survival after out-of-hospital cardiac arrest","volume":"8","author":"Vyas","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B404","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4244\/EIJV10I1A7","article-title":"Invasive coronary treatment strategies for out-of-hospital cardiac arrest: A consensus statement from the European Association for Percutaneous Cardiovascular Interventions (EAPCI)\/Stent for Life (SFL) groups","volume":"10","author":"Noc","year":"2014","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B405","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"50","author":"Kirchhof","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B406","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.amjcard.2011.10.004","article-title":"Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention","volume":"109","author":"Chan","year":"2012","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B407","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/eurheartj\/ehp213","article-title":"Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: Results from the APEX-AMI trial","volume":"30","author":"Lopes","year":"2009","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B408","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCA.0b013e32834df552","article-title":"Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: Insight into the RISK-PCI trial","volume":"23","author":"Mrdovic","year":"2012","journal-title":"Coron Artery Dis"},{"key":"2025110203570931700_ezy289-B409","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.4244\/EIJV8I9A163","article-title":"Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents","volume":"8","author":"Pilgrim","year":"2013","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B410","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","article-title":"ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the","volume":"53","author":"Valgimigli","year":"2018","journal-title":"European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B411","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.athoracsur.2006.11.047","article-title":"Postoperative atrial fibrillation is not correlated to C-reactive protein","volume":"83","author":"Ahlsson","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B412","first-page":"CD003611","article-title":"Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery","volume":"1","author":"Arsenault","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025110203570931700_ezy289-B413","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/jama.291.14.1720","article-title":"A multicenter risk index for atrial fibrillation after cardiac surgery","volume":"291","author":"Mathew","year":"2004","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B414","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jtcvs.2010.03.011","article-title":"The persistent problem of new-onset postoperative atrial fibrillation: A single-institution experience over two decades","volume":"141","author":"Shen","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B415","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.athoracsur.2014.03.039","article-title":"Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs","volume":"98","author":"LaPar","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B416","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.amjcard.2011.08.033","article-title":"Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients)","volume":"109","author":"Saxena","year":"2012","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B417","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/clc.22230","article-title":"Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: Insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry","volume":"37","author":"Steinberg","year":"2014","journal-title":"Clin Cardiol"},{"key":"2025110203570931700_ezy289-B418","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/14017430802702291","article-title":"Patients with postoperative atrial fibrillation have a doubled cardiovascular mortality","volume":"43","author":"Ahlsson","year":"2009","journal-title":"Scand Cardiovasc J"},{"key":"2025110203570931700_ezy289-B419","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.ejcts.2009.12.033","article-title":"Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality","volume":"37","author":"Ahlsson","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B420","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jama.2014.9143","article-title":"Perioperative atrial fibrillation and the long-term risk of ischemic stroke","volume":"312","author":"Gialdini","year":"2014","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B421","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.108.777789","article-title":"Atrial fibrillation after isolated coronary surgery affects late survival","volume":"118","author":"Mariscalco","year":"2008","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B422","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2003.11.023","article-title":"Postoperative atrial fibrillation and mortality after coronary artery bypass surgery","volume":"43","author":"Villareal","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B423","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/eurheartj\/ehl272","article-title":"Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: A meta-analysis","volume":"27","author":"Burgess","year":"2006","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B424","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1067\/mhj.2003.147","article-title":"Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study","volume":"145","author":"Connolly","year":"2003","journal-title":"Am Heart J"},{"key":"2025110203570931700_ezy289-B425","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.CIR.0000021113.44111.3E","article-title":"Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: A meta-analysis","volume":"106","author":"Crystal","year":"2002","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B426","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ejcts.2006.09.003","article-title":"Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery","volume":"30","author":"Dunning","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B427","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1749-8090-5-121","article-title":"Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: A systematic review","volume":"5","author":"Koniari","year":"2010","journal-title":"J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B428","first-page":"42","article-title":"Effectiveness of metoprolol in preventing atrial fibrillation and flutter in the postoperative period of coronary artery bypass graft surgery","volume":"82","author":"Lucio Ede","year":"2004","journal-title":"Arq Bras Cardiol"},{"key":"2025110203570931700_ezy289-B429","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1253\/circj.72.588","article-title":"Postoperative treatment with carvedilol, a beta-adrenergic blocker, prevents paroxysmal atrial fibrillation after coronary artery bypass grafting","volume":"72","author":"Tsuboi","year":"2008","journal-title":"Circ J"},{"key":"2025110203570931700_ezy289-B430","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cll.2014.06.012","article-title":"Anticoagulation strategies for the management of postoperative atrial fibrillation","volume":"34","author":"Anderson","year":"2014","journal-title":"Clin Lab Med"},{"key":"2025110203570931700_ezy289-B431","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jacc.2009.10.058","article-title":"New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft","volume":"55","author":"El-Chami","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B432","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.116.021952","article-title":"Impact of left atrial appendage closure during cardiac surgery on the occurrence of early postoperative atrial fibrillation, stroke, and mortality: A propensity score-matched analysis of 10\u2009633 patients","volume":"135","author":"Melduni","year":"2017","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B433","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ejcts\/ezu291","article-title":"Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: A meta-analysis","volume":"47","author":"Tsai","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B434","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.2017.20125","article-title":"Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing concomitant cardiac surgery","volume":"319","author":"Friedman","year":"2018","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B435","first-page":"45","article-title":"Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III","volume":"3","author":"Whitlock","year":"2014","journal-title":"Ann Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B436","article-title":"Emergent percutaneous coronary intervention for resuscitated victims of out-of-hospital cardiac arrest","author":"Kern","journal-title":"Catheter Cardiovasc Interv 2010;75:616\u2013624"},{"key":"2025110203570931700_ezy289-B437","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.resuscitation.2014.06.001","article-title":"Post-resuscitation electrocardiograms, acute coronary findings and in-hospital prognosis of survivors of out-of-hospital cardiac arrest","volume":"85","author":"Garcia-Tejada","year":"2014","journal-title":"Resuscitation"},{"key":"2025110203570931700_ezy289-B438","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/anec.12004","article-title":"Prevention of post-coronary artery bypass grafting (CABG) atrial fibrillation: Efficacy of prophylactic beta-blockers in the modern era: A meta-analysis of latest randomized controlled trials","volume":"18","author":"Khan","year":"2013","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2025110203570931700_ezy289-B439","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/pace.12140","article-title":"Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: A network regression meta-analysis","volume":"36","author":"Chatterjee","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"2025110203570931700_ezy289-B440","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: The Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B441","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"2025110203570931700_ezy289-B442","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B443","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/CIRCULATIONAHA.116.022572","article-title":"Current practice of state-of-the-art surgical coronary revascularization","volume":"136","author":"Head","year":"2017","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B444","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ejcts\/ezx325","article-title":"2017 EACTS\/EACTA Guidelines on patient blood management for adult cardiac surgery","volume":"53","author":"Task Force on Patient Blood Management for Adult Cardiac Surgery of the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Cardiothoracic Anaesthesiology (EACTA)","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B445","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/ejcts\/ezr105","article-title":"Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: A subgroup analysis of 3-year SYNTAX data","volume":"41","author":"Head","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B446","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/CIRCULATIONAHA.110.005041","article-title":"Impact of angiographic complete revascularization after drug-eluting stent implantation or coronary artery bypass graft surgery for multivessel coronary artery disease","volume":"123","author":"Kim","year":"2011","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B447","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.athoracsur.2012.02.033","article-title":"Completeness of revascularization and survival among octogenarians with triple-vessel disease","volume":"93","author":"Mohammadi","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B448","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1161\/CIRCULATIONAHA.108.842005","article-title":"Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery?","volume":"120","author":"Rastan","year":"2009","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B449","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jss.2013.05.042","article-title":"Association of incomplete revascularization with long-term survival after off-pump coronary artery bypass grafting","volume":"185","author":"Yi","year":"2013","journal-title":"J Surg Res"},{"key":"2025110203570931700_ezy289-B450","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1067\/mtc.2000.107280","article-title":"Isolated bypass grafting of the left internal thoracic artery to the left anterior descending coronary artery: Late consequences of incomplete revascularization","volume":"120","author":"Scott","year":"2000","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B451","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.athoracsur.2016.01.065","article-title":"Complete coronary revascularization improves survival in octogenarians","volume":"102","author":"Melby","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B452","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/j.athoracsur.2007.01.027","article-title":"Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study","volume":"83","author":"Botman","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B453","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-5223(94)70320-5","article-title":"Surgical treatment of isolated left anterior descending coronary stenosis. Comparison of left internal mammary artery and venous autograft at 18 to 20 years of follow-up","volume":"107","author":"Boylan","year":"1994","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B454","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jtcvs.2005.05.024","article-title":"Influence of patient characteristics and arterial grafts on freedom from coronary reoperation","volume":"131","author":"Sabik","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B455","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/HCO.0b013e32833f0498","article-title":"Prevalence and variability of internal mammary graft use in contemporary multivessel coronary artery bypass graft","volume":"25","author":"Schmitto","year":"2010","journal-title":"Curr Opin Cardiol"},{"key":"2025110203570931700_ezy289-B456","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCULATIONAHA.113.008193","article-title":"Saphenous vein graft failure after coronary artery bypass surgery: Insights from PREVENT IV","volume":"130","author":"Hess","year":"2014","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B457","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ejcts\/ezu111","article-title":"Searching for the second best graft for coronary artery bypass surgery: A network meta-analysis of randomized controlled trials","volume":"47","author":"Benedetto","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B458","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1161\/CIRCULATIONAHA.112.117606","article-title":"Bilateral internal mammary artery grafting enhances survival in diabetic patients: A 30-year follow-up of propensity score-matched cohorts","volume":"126","author":"Dorman","year":"2012","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B459","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jtcvs.2011.12.026","article-title":"Bilateral internal thoracic artery grafting improves long-term survival in patients with reduced ejection fraction: A propensity-matched study with 30-year follow-up","volume":"143","author":"Galbut","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B460","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/ejcts\/ezr213","article-title":"Propensity matched analysis of bilateral internal mammary artery versus single left internal mammary artery grafting at 17-year follow-up: Validation of a contemporary surgical experience","volume":"41","author":"Grau","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B461","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.athoracsur.2010.04.006","article-title":"Thirty-year follow-up defines survival benefit for second internal mammary artery in propensity-matched groups","volume":"90","author":"Kurlansky","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B462","first-page":"485","article-title":"Bilateral internal thoracic artery grafting","volume":"2","author":"Lytle","year":"2013","journal-title":"Ann Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B463","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/CIRCULATIONAHA.111.030536","article-title":"Second internal thoracic artery versus radial artery in coronary artery bypass grafting: A long-term, propensity score-matched follow-up study","volume":"124","author":"Ruttmann","year":"2011","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B464","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(01)06069-X","article-title":"Effect of arterial revascularisation on survival: A systematic review of studies comparing bilateral and single internal mammary arteries","volume":"358","author":"Taggart","year":"2001","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B465","first-page":"390","article-title":"A meta-analysis comparing bilateral internal mammary artery with left internal mammary artery for coronary artery bypass grafting","volume":"2","author":"Weiss","year":"2013","journal-title":"Ann Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B466","doi-asserted-by":"crossref","first-page":"e008010","DOI":"10.1161\/JAHA.117.008010","article-title":"Unmeasured confounders in observational studies comparing bilateral versus single internal thoracic artery for coronary artery bypass grafting: A meta-analysis","volume":"7","author":"Gaudino","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2025110203570931700_ezy289-B467","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1610021","article-title":"Randomized trial of bilateral versus single internal-thoracic-artery grafts","volume":"375","author":"Taggart","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B468","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1056\/NEJMc1703358","article-title":"Bilateral versus single internal-thoracic-artery grafts","volume":"376","author":"Gaudino","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B469","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1056\/NEJMc1703358","article-title":"Bilateral versus single internal-thoracic-artery grafts","volume":"376","author":"Raza","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B470","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1056\/NEJMc1703358","article-title":"Bilateral versus single internal-thoracic-artery grafts","volume":"376","author":"Royse","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B471","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.athoracsur.2012.11.068","article-title":"Bilateral internal thoracic artery harvest and deep sternal wound infection in diabetic patients","volume":"95","author":"Deo","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B472","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1540-8191.2011.01325.x","article-title":"Is bilateral internal thoracic artery use safe in the elderly?","volume":"27","author":"Elmistekawy","year":"2012","journal-title":"J Card Surg"},{"key":"2025110203570931700_ezy289-B473","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jtcvs.2012.04.024","article-title":"Long-term outcomes of patients with diabetes receiving bilateral internal thoracic artery grafts","volume":"146","author":"Hemo","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B474","article-title":"Protocol for the Arterial Revascularisation Trial (ART). A randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265]","volume":"7:7","author":"Taggart","year":"2006","journal-title":"Trials"},{"key":"2025110203570931700_ezy289-B475","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1510\/icvts.2007.164343","article-title":"Does bilateral internal thoracic artery harvest increase the risk of mediastinitis?","volume":"6","author":"Toumpoulis","year":"2007","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203570931700_ezy289-B476","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jtcvs.2016.03.056","article-title":"Pedicled and skeletonized single and bilateral internal thoracic artery grafts and the incidence of sternal wound complications: Insights from the Arterial Revascularization Trial","volume":"152","author":"Benedetto","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B477","doi-asserted-by":"crossref","first-page":"60\u20135","DOI":"10.1016\/j.jtcvs.2009.09.043","article-title":"Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: Results from the Radial Artery Patency and Clinical Outcomes trial","volume":"139","author":"Hayward","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B478","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.athoracsur.2012.05.029","article-title":"Comparison of late coronary artery bypass graft survival effects of radial artery versus saphenous vein grafting in male and female patients","volume":"94","author":"Schwann","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B479","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.athoracsur.2010.05.038","article-title":"Radial artery conduits improve long-term survival after coronary artery bypass grafting","volume":"90","author":"Tranbaugh","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B480","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1161\/CIRCULATIONAHA.111.083048","article-title":"Coronary artery bypass grafting using the radial artery: Clinical outcomes, patency, and need for reintervention","volume":"126","author":"Tranbaugh","year":"2012","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B481","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jtcvs.2012.07.014","article-title":"Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: A meta-analysis of randomized controlled trials","volume":"146","author":"Cao","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B482","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa1716026","article-title":"Radial-artery or saphenous-vein grafts in coronary-artery bypass surgery","volume":"378","author":"Gaudino","year":"2018","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B483","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1067\/mtc.2001.111654","article-title":"Skeletonized internal thoracic artery grafts and wound complications","volume":"121","author":"Lytle","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B484","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/icvts\/ivt012","article-title":"Skeletonized versus pedicled internal thoracic artery and risk of sternal wound infection after coronary bypass surgery: Meta-analysis and meta-regression of 4817 patients","volume":"16","author":"Sa","year":"2013","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203570931700_ezy289-B485","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/icvts\/ivt089","article-title":"Simple adaptations of surgical technique to critically reduce the risk of postoperative sternal complications in patients receiving bilateral internal thoracic arteries","volume":"17","author":"Sakic","year":"2013","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203570931700_ezy289-B486","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0022-5223(99)70053-X","article-title":"T grafts with the right internal thoracic artery to left internal thoracic artery versus the left internal thoracic artery and radial artery: Flow dynamics in the internal thoracic artery main stem","volume":"118","author":"Wendler","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B487","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.athoracsur.2014.09.045","article-title":"Coronary artery bypass revascularization using bilateral internal thoracic arteries in diabetic patients: A systematic review and meta-analysis","volume":"99","author":"Kajimoto","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B488","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ejcts\/ezu344","article-title":"Flow capacity of skeletonized versus pedicled internal thoracic artery in coronary artery bypass graft surgery: Systematic review, meta-analysis and meta-regression","volume":"48","author":"Sa","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B489","first-page":"557","article-title":"Endoscopic radial artery harvesting procedure for coronary artery bypass grafting","volume":"2","author":"Navia","year":"2013","journal-title":"Ann Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B490","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/imi.0000000000000087","article-title":"A meta-analysis of endoscopic versus conventional open radial artery harvesting for coronary artery bypass graft surgery","volume":"9","author":"Cao","year":"2014","journal-title":"Innovations (Phila)"},{"key":"2025110203570931700_ezy289-B491","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/ejcts\/ezu456","article-title":"Morphological and functional consequences of transradial coronary angiography on the radial artery: Implications for its use as a bypass conduit","volume":"48","author":"Gaudino","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B492","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.athoracsur.2009.09.061","article-title":"Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting","volume":"89","author":"Ouzounian","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B493","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jtcvs.2004.08.054","article-title":"Randomized trial of endoscopic versus open vein harvest for coronary artery bypass grafting: Six-month patency rates","volume":"129","author":"Yun","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B494","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13019-015-0353-3","article-title":"Comparative results of endoscopic and open methods of vein harvesting for coronary artery bypass grafting: A prospective randomized parallel-group trial","volume":"10","author":"Chernyavskiy","year":"2015","journal-title":"J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B495","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/icvts\/ivs164","article-title":"A randomized study comparing three groups of vein harvesting methods for coronary artery bypass grafting: endoscopic harvest versus standard bridging and open techniques","volume":"15","author":"Krishnamoorthy","year":"2012","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203570931700_ezy289-B496","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa0900708","article-title":"Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery","volume":"361","author":"Lopes","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B497","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jtcvs.2010.10.004","article-title":"Impact of endoscopic versus open saphenous vein harvest technique on late coronary artery bypass grafting patient outcomes in the ROOBY (Randomized On\/Off Bypass) Trial","volume":"141","author":"Zenati","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B498","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/14017431.2015.1060354","article-title":"Decreased patency rates following endoscopic vein harvest in coronary artery bypass surgery","volume":"49","author":"Andreasen","year":"2015","journal-title":"Scand Cardiovasc J"},{"key":"2025110203570931700_ezy289-B499","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jss.2012.11.013","article-title":"Endoscopic vein harvesting for coronary artery bypass grafting: A systematic review with meta-analysis of 27,789 patients","volume":"180","author":"Deppe","year":"2013","journal-title":"J Surg Res"},{"key":"2025110203570931700_ezy289-B500","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jama.2012.8363","article-title":"Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery","volume":"308","author":"Williams","year":"2012","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B501","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jtcvs.2007.07.042","article-title":"Strategies to reduce intraluminal clot formation in endoscopically harvested saphenous veins","volume":"134","author":"Brown","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B502","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.athoracsur.2011.10.035","article-title":"High-pressure distention of the saphenous vein during preparation results in increased markers of inflammation: A potential mechanism for graft failure","volume":"93","author":"Khaleel","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B503","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.athoracsur.2008.08.049","article-title":"Saphenous vein conduits harvested by endoscopic technique exhibit structural and functional damage","volume":"87","author":"Rousou","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B504","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejcts.2010.02.007","article-title":"Slower progression of atherosclerosis in vein grafts harvested with \u2018touch\u2019 technique compared with conventional harvesting technique in coronary artery bypass grafting: An angiographic and intravascular ultrasound study","volume":"38","author":"Johansson","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B505","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0003-4975(02)03425-2","article-title":"Improved patency in vein grafts harvested with surrounding tissue: Results of a randomized study using three harvesting techniques","volume":"73","author":"Souza","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B506","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.athoracsur.2013.01.102","article-title":"The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting","volume":"96","author":"Dreifaldt","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B507","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jtcvs.2015.07.027","article-title":"The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: A randomized trial","volume":"150","author":"Samano","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B508","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jtcvs.2011.04.031","article-title":"Aortic no-touch technique makes the difference in off-pump coronary artery bypass grafting","volume":"142","author":"Emmert","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B509","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1161\/CIRCULATIONAHA.111.084285","article-title":"Clampless off-pump versus conventional coronary artery revascularization: A propensity score analysis of 788 patients","volume":"126","author":"Borgermann","year":"2012","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B510","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jtcvs.2010.11.034","article-title":"Neurologic complications after off-pump coronary artery bypass grafting with and without aortic manipulation: Meta-analysis of 11,398 cases from 8 studies","volume":"142","author":"Misfeld","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B511","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jtcvs.2006.10.002","article-title":"Gaseous and solid cerebral microembolization during proximal aortic anastomoses in off-pump coronary surgery: The effect of an aortic side-biting clamp and two clampless devices","volume":"133","author":"Guerrieri Wolf","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B512","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/icvts\/ivr004","article-title":"Avoiding the clamp during off-pump coronary artery bypass reduces cerebral embolic events: Results of a prospective randomized trial","volume":"14","author":"El Zayat","year":"2012","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"2025110203570931700_ezy289-B513","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejcts.2010.01.026","article-title":"Transit-time flow predicts outcomes in coronary artery bypass graft patients: A series of 1000 consecutive arterial grafts","volume":"38","author":"Kieser","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B514","doi-asserted-by":"crossref","first-page":"275","DOI":"10.17305\/bjbms.2007.3059","article-title":"Transit time flowmetry in coronary surgery\u2013an important tool in graft verification","volume":"7","author":"Mujanovic","year":"2007","journal-title":"Bosn J Basic Med Sci"},{"key":"2025110203570931700_ezy289-B515","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ejcts.2010.10.006","article-title":"Clinical value of intra-operative transit-time flow measurement for coronary artery bypass grafting: A prospective angiography-controlled study","volume":"39","author":"Jokinen","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B516","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jocs.12471","article-title":"Transit-time flow measurement as a predictor of coronary bypass graft failure at one year angiographic follow-up","volume":"30","author":"Lehnert","year":"2015","journal-title":"J Card Surg"},{"key":"2025110203570931700_ezy289-B517","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/ejcts\/ezw203","article-title":"Techniques and standards in intraoperative graft verification by transit time flow measurement after coronary artery bypass graft surgery: A critical review","volume":"51","author":"Niclauss","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B518","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1211666","article-title":"Off-pump versus on-pump coronary-artery bypass grafting in elderly patients","volume":"368","author":"Diegeler","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B519","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1200388","article-title":"Off-pump or on-pump coronary-artery bypass grafting at 30 days","volume":"366","author":"Lamy","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B520","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa1301228","article-title":"Effects of off-pump and on-pump coronary-artery bypass grafting at 1 year","volume":"368","author":"Lamy","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B521","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/CIRCULATIONAHA.111.069260","article-title":"Off-pump coronary artery bypass surgery is associated with worse arterial and saphenous vein graft patency and less effective revascularization: Results from the Veterans Affairs Randomized On\/Off Bypass (ROOBY) trial","volume":"125","author":"Hattler","year":"2012","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B522","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1161\/CIRCULATIONAHA.111.052571","article-title":"On-pump versus off-pump coronary artery bypass surgery in elderly patients: Results from the Danish on-pump versus off-pump randomization study","volume":"125","author":"Houlind","year":"2012","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B523","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa0902905","article-title":"On-pump versus off-pump coronary-artery bypass surgery","volume":"361","author":"Shroyer","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B524","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jtcvs.2012.09.035","article-title":"Off-pump coronary artery bypass grafting attenuates morbidity and mortality for patients with low and high body mass index","volume":"146","author":"Keeling","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B525","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.athoracsur.2009.04.135","article-title":"Off-pump coronary artery bypass disproportionately benefits high-risk patients","volume":"88","author":"Puskas","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B526","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.athoracsur.2010.12.043","article-title":"Off-pump and on-pump coronary artery bypass grafting are associated with similar graft patency, myocardial ischemia, and freedom from reintervention: Long-term follow-up of a randomized trial","volume":"91","author":"Puskas","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B527","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1161\/01.STR.0000245081.52877.f2","article-title":"Off-pump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting: A meta-analysis of systematically reviewed trials","volume":"37","author":"Sedrakyan","year":"2006","journal-title":"Stroke"},{"key":"2025110203570931700_ezy289-B528","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.athoracsur.2014.12.057","article-title":"Off-pump coronary artery bypass reduces early stroke in octogenarians: A meta-analysis of 18,000 patients","volume":"99","author":"Altarabsheh","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B529","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1681\/ASN.2012020122","article-title":"Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function","volume":"23","author":"Chawla","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2025110203570931700_ezy289-B530","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/eht284","article-title":"Coronary artery bypass grafting: Part 2\u2013optimizing outcomes and future prospects","volume":"34","author":"Head","year":"2013","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B531","first-page":"290","article-title":"Comparison of MIDCAP versus conventional CABG surgery regarding pain and quality of life","volume":"2","author":"Diegeler","year":"1999","journal-title":"Heart Surg Forum"},{"key":"2025110203570931700_ezy289-B532","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0003-4975(99)00949-2","article-title":"Port-access coronary artery bypass grafting: Technique and comparative results","volume":"68","author":"Groh","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B533","first-page":"804","article-title":"Minimally invasive coronary artery bypass grafting via a small thoracotomy versus off-pump: A case-matched study","volume":"40","author":"Lapierre","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B534","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ejcts\/ezu285","article-title":"Minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for single-vessel disease: A meta-analysis of 2885 patients","volume":"47","author":"Deppe","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B535","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13019-016-0512-1","article-title":"Minimally invasive direct coronary bypass compared with percutaneous coronary intervention for left anterior descending artery disease: A meta-analysis","volume":"11","author":"Wang","year":"2016","journal-title":"J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B536","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jcin.2014.05.025","article-title":"Hybrid revascularization for multivessel coronary artery disease","volume":"7","author":"Gasior","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B537","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.athoracsur.2012.05.041","article-title":"Hybrid coronary revascularization using robotic totally endoscopic surgery: Perioperative outcomes and 5-year results","volume":"94","author":"Bonatti","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B538","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2013.04.007","article-title":"One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from","volume":"61","author":"Shen","year":"2013","journal-title":"a single institution. J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B539","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jtcvs.2013.10.019","article-title":"Standardizing definitions for hybrid coronary revascularization","volume":"147","author":"Harskamp","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B540","first-page":"460","article-title":"Prospective randomised pilOt study evaLuating the safety and efficacy of hybrid revascularisation in MultI-vessel coronary artery DisEaSe (POLMIDES) - study design","volume":"69","author":"Zembala","year":"2011","journal-title":"Kardiol Pol"},{"key":"2025110203570931700_ezy289-B541","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcin.2018.01.271","article-title":"Hybrid coronary revascularization in selected patients with multivessel disease: 5-year clinical outcomes of the prospective randomized pilot study","volume":"11","author":"Tajstra","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B542","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jacc.2014.04.093","article-title":"Hybrid coronary revascularization: Promising, but yet to take off","volume":"65","author":"Panoulas","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B543","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/ejcts\/ezt119","article-title":"Evaluation of cardiac surgery mortality rates: 30-day mortality or longer follow-up?","volume":"44","author":"Siregar","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B544","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jacc.2016.11.071","article-title":"Coronary artery bypass grafting with and without manipulation of the ascending aorta: A network meta-analysis","volume":"69","author":"Zhao","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B545","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jtcvs.2014.09.011","article-title":"Avoiding aortic clamping during coronary artery bypass grafting reduces postoperative stroke","volume":"149","author":"Moss","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B546","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jacc.2013.08.1632","article-title":"Adoption and effectiveness of internal mammary artery grafting in coronary artery bypass surgery among Medicare beneficiaries","volume":"63","author":"Hlatky","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B547","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.athoracsur.2011.05.083","article-title":"Outcomes associated with bilateral internal thoracic artery grafting: the importance of age","volume":"92","author":"Kieser","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B548","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/CIRCULATIONAHA.113.004255","article-title":"Effect of bilateral internal mammary artery grafts on long-term survival: A meta-analysis approach","volume":"130","author":"Yi","year":"2014","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B549","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.117.027659","article-title":"Associations between adding a radial artery graft to single and bilateral internal thoracic artery grafts and outcomes: Insights from the Arterial Revascularization Trial","volume":"136","author":"Taggart","year":"2017","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B550","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.athoracsur.2016.02.107","article-title":"Comparison of radial artery and saphenous vein graft stenosis more than 5 years after coronary artery bypass grafting","volume":"102","author":"Yamasaki","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B551","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.jtcvs.2014.07.088","article-title":"Guidance for the use of bilateral internal thoracic arteries according to survival benefit across age groups","volume":"148","author":"Benedetto","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B552","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa040982","article-title":"A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts","volume":"351","author":"Desai","year":"2004","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B553","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jacc.2016.05.062","article-title":"Radial artery as a coronary artery bypass conduit: 20-year results","volume":"68","author":"Gaudino","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B554","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/CIRCULATIONAHA.110.960765","article-title":"Long-term outcomes of endoscopic vein harvesting after coronary artery bypass grafting","volume":"123","author":"Dacey","year":"2011","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B555","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1532\/HSF98.20131006","article-title":"Comparison of conventional and no-touch techniques in harvesting saphenous vein for coronary artery bypass grafting in view of endothelial damage","volume":"16","author":"Sen","year":"2013","journal-title":"Heart Surg Forum"},{"key":"2025110203570931700_ezy289-B556","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.athoracsur.2016.09.024","article-title":"No-touch saphenous vein harvesting may improve further the patency of saphenous vein composite grafts: Early outcomes and 1-year angiographic results","volume":"103","author":"Kim","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B557","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjcard.2017.11.035","article-title":"Comparison of outcomes for off-pump versus on-pump coronary artery bypass grafting in low-volume and high-volume centers and by low-volume and high-volume surgeons","volume":"121","author":"Benedetto","year":"2018","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B558","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jtcvs.2011.12.048","article-title":"The effect of surgeon volume on mortality for off-pump coronary artery bypass grafting","volume":"143","author":"Lapar","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B559","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehr307","article-title":"Off-pump vs on-pump coronary artery bypass surgery: An updated meta-analysis and meta-regression of randomized trials","volume":"33","author":"Afilalo","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B560","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jtcvs.2011.11.011","article-title":"On-pump versus off-pump coronary artery bypass surgery in high-risk patients: Operative results of a prospective randomized trial (on-off study)","volume":"143","author":"Lemma","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B561","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jtcvs.2015.10.061","article-title":"Hybrid coronary revascularization versus coronary artery bypass surgery with bilateral or single internal mammary artery grafts","volume":"151","author":"Rosenblum","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B562","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCULATIONAHA.114.009479","article-title":"Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: An analysis from the society of thoracic surgeons adult cardiac database","volume":"130","author":"Harskamp","year":"2014","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B563","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacc.2016.05.032","article-title":"Hybrid coronary revascularization for the treatment of multivessel coronary artery disease:","volume":"68","author":"Puskas","year":"2016","journal-title":"A multicenter observational study. J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B564","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.7326\/0003-4819-138-10-200305200-00005","article-title":"Evidence for use of coronary stents. A hierarchical bayesian meta-analysis","volume":"138","author":"Brophy","year":"2003","journal-title":"Ann Intern Med"},{"key":"2025110203570931700_ezy289-B565","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","article-title":"Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study","volume":"382","author":"Mehran","year":"2013","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B566","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/eurheartj\/ehu026","article-title":"Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation","volume":"35","author":"Silber","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B567","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","article-title":"Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO) trial","volume":"103","author":"Kastrati","year":"2001","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B568","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0735-1097(03)00119-0","article-title":"Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial","volume":"41","author":"Pache","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B569","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B570","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B571","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: A prospective cohort study","volume":"125","author":"Raber","year":"2012","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B572","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B573","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B574","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(12)61962-X","article-title":"Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): A randomised non-inferiority trial","volume":"381","author":"Christiansen","year":"2013","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B575","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/eurheartj\/ehp352","article-title":"Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: The Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial","volume":"30","author":"Byrne","year":"2009","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B576","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)61852-2","article-title":"Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial","volume":"381","author":"Smits","year":"2013","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B577","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.111.026732","article-title":"Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial","volume":"124","author":"Massberg","year":"2011","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B578","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/eurheartj\/ehv203","article-title":"Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: Executive summary","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B579","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-eluting or bare-metal stents for coronary artery disease","volume":"375","author":"Bonaa","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B580","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B581","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(17)32713-7","article-title":"Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): A randomised single-blind trial","volume":"391","author":"Varenne","year":"2018","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B582","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/eht570","article-title":"Biodegradable-polymer drug-eluting stents vs bare metal stents vs durable-polymer drug-eluting stents: A systematic review and Bayesian approach network meta-analysis","volume":"35","author":"Kang","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B583","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0140-6736(14)61038-2","article-title":"Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial","volume":"384","author":"Pilgrim","year":"2014","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B584","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.114.013520","article-title":"Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: Main results of the Basel Stent Kosten-Effektivitats Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial","volume":"131","author":"Kaiser","year":"2015","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B585","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(14)61794-3","article-title":"Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): A randomised non-inferiority trial","volume":"385","author":"Raungaard","year":"2015","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B586","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","article-title":"Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): A three-arm, randomised, non-inferiority trial","volume":"388","author":"von Birgelen","year":"2016","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B587","doi-asserted-by":"crossref","first-page":"e002372","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372","article-title":"Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: The EVOLVE II Randomized Trial","volume":"8","author":"Kereiakes","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B588","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jacc.2013.04.045","article-title":"Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: A randomized, controlled, noninferiority trial","volume":"62","author":"Natsuaki","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B589","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/eurheartj\/ehu210","article-title":"A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: The CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial","volume":"35","author":"Saito","year":"2014","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B590","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): A randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B591","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcin.2016.01.009","article-title":"ISAR-TEST 5 Investigators. Randomized trial of polymer-free sirolimus- and probucol-eluting stents versus durable polymer zotarolimus-eluting stents: 5-year results of the ISAR-TEST-5 trial","volume":"9","author":"Kufner","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B592","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.4244\/EIJY14M11_02","article-title":"Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: Final results from the ISAR-TEST 4 randomised trial","volume":"11","author":"Kufner","year":"2016","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B593","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jcin.2017.02.029","article-title":"Biodegradable polymer biolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with coronary artery disease: Final 5-year report from the COMPARE II Trial (abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent)","volume":"10","author":"Vlachojannis","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B594","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.4244\/EIJ-D-16-00773","article-title":"Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE\/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) randomised trials","volume":"12","author":"Vlachojannis","year":"2017","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B595","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1016\/j.jacc.2014.09.041","article-title":"Current status of bioresorbable scaffolds in the treatment of coronary artery disease","volume":"64","author":"Wiebe","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B596","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/j.jacc.2017.04.011","article-title":"Everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents","volume":"69","author":"Sorrentino","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B597","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.117.028479","article-title":"Temporal trends in adverse events after everolimus-eluting bioresorbable vascular scaffold versus everolimus-eluting metallic stent implantation: A meta-analysis of randomized controlled trials","volume":"135","author":"Montone","year":"2017","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B598","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4244\/EIJV8I4A70","article-title":"Comparison of two drug-eluting balloons: A report from the SCAAR registry","volume":"8","author":"Bondesson","year":"2012","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B599","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","article-title":"A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The BELLO (Balloon Elution and Late Loss Optimization) study","volume":"60","author":"Latib","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B600","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","article-title":"Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study","volume":"96","author":"Cortese","year":"2010","journal-title":"Heart"},{"key":"2025110203570931700_ezy289-B601","first-page":"1138","article-title":"A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: Six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial","volume":"80","author":"Stella","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B602","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2012.07.017","article-title":"High-speed rotational atherectomy before paclitaxel-eluting stent implantation in complex calcified coronary lesions: The randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) trial","volume":"6","author":"Abdel-Wahab","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B603","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjcard.2010.09.030","article-title":"Meta-analysis of randomized studies comparing intravascular ultrasound versus angiographic guidance of percutaneous coronary intervention in pre-drug-eluting stent era","volume":"107","author":"Parise","year":"2011","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B604","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2046-4053-1-42","article-title":"Does intravascular ultrasound provide clinical benefits for percutaneous coronary intervention with bare-metal stent implantation? A meta-analysis of randomized controlled trials","volume":"1","author":"Lodi-Junqueira","year":"2012","journal-title":"Syst Rev"},{"key":"2025110203570931700_ezy289-B605","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.4244\/EIJ-D-16-00769","article-title":"Intravascular ultrasound guidance improves clinical outcomes during implantation of both first- and second-generation drug-eluting stents: A meta-analysis","volume":"12","author":"Nerlekar","year":"2017","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B606","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.jcin.2017.08.051","article-title":"Clinical outcomes following intravascular imaging-guided versus coronary angiography-guided percutaneous coronary intervention with stent implantation: A systematic review and Bayesian network meta-analysis of 31 studies and 17,882 patients","volume":"10","author":"Buccheri","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B607","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4244\/EIJV8I7A125","article-title":"Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: The Centro per la Lotta contro l'Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study","volume":"8","author":"Prati","year":"2012","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B608","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1093\/eurheartj\/ehv367","article-title":"Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study","volume":"36","author":"Wijns","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B609","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1093\/eurheartj\/ehs095","article-title":"Expert's OCT Review Document. Expert review document part 2: Methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures","volume":"33","author":"Prati","year":"2012","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B610","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.4244\/EIJV9I9A183","article-title":"Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation","volume":"9","author":"Radu","year":"2014","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B611","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1016\/S0140-6736(16)31922-5","article-title":"Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): A randomised controlled trial","volume":"388","author":"Ali","year":"2016","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B612","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.116.024393","article-title":"Optical coherence tomography to optimize results of percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome: Results of the multicenter, randomized DOCTORS study (Does Optical Coherence Tomography Optimize Results of Stenting)","volume":"134","author":"Meneveau","year":"2016","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B613","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/CIRCULATIONAHA.115.019071","article-title":"Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography","volume":"133","author":"Taniwaki","year":"2016","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B614","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/eurheartj\/ehv711","article-title":"Mechanisms of stent thrombosis analysed by optical coherence tomography: Insights from the national PESTO French registry","volume":"37","author":"Souteyrand","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B615","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1161\/CIRCULATIONAHA.110.988436","article-title":"Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation","volume":"123","author":"Kang","year":"2011","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B616","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1161\/ATVBAHA.113.301227","article-title":"Tissue characterization after drug-eluting stent implantation using optical coherence tomography","volume":"33","author":"Malle","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025110203570931700_ezy289-B617","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4244\/EIJY14M06_06","article-title":"Stenting strategy for coronary artery bifurcation with drug-eluting stents: A meta-analysis of nine randomised trials and systematic review","volume":"10","author":"Gao","year":"2014","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B618","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/eurheartj\/ehw170","article-title":"Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study","volume":"37","author":"Behan","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B619","doi-asserted-by":"crossref","first-page":"e003643","DOI":"10.1161\/CIRCINTERVENTIONS.115.003643","article-title":"The EBC TWO Study (European Bifurcation Coronary TWO): A randomized comparison of provisional T-stenting versus a systematic 2 stent culotte strategy in large caliber true bifurcations","volume":"9","author":"Hildick-Smith","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B620","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jacc.2017.09.1066","article-title":"Double kissing crush versus provisional stenting for left main distal bifurcation lesions: DKCRUSH-V randomized trial","volume":"70","author":"Chen","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B621","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCINTERVENTIONS.108.804658","article-title":"Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: The Nordic stent technique study","volume":"2","author":"Erglis","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B622","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4103\/0366-6999.176997","article-title":"Randomized comparison of the crush versus the culotte stenting for coronary artery bifurcation lesions","volume":"129","author":"Zheng","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"2025110203570931700_ezy289-B623","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jacc.2013.01.023","article-title":"Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: Results from a multicenter, randomized, prospective DKCRUSH-III study","volume":"61","author":"Chen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B624","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCULATIONAHA.110.966879","article-title":"Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting: The Nordic-Baltic Bifurcation Study III","volume":"123","author":"Niemela","year":"2011","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B625","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/heartjnl-2011-300322","article-title":"Final kissing ballooning and long-term clinical outcomes in coronary bifurcation lesions treated with 1-stent technique: Results from the COBIS registry","volume":"98","author":"Gwon","year":"2012","journal-title":"Heart"},{"key":"2025110203570931700_ezy289-B626","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2014.11.031","article-title":"A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions","volume":"65","author":"Genereux","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B627","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4244\/EIJV12I1A7","article-title":"Percutaneous coronary intervention for coronary bifurcation disease: 11th consensus document from the European Bifurcation Club","volume":"12","author":"Lassen","year":"2016","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B628","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2016.07.744","article-title":"Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: The EXPLORE trial","volume":"68","author":"Henriques","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B629","first-page":"2484","author":"Werner","year":"2018"},{"key":"2025110203570931700_ezy289-B630","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.amjcard.2015.02.038","article-title":"Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions","volume":"115","author":"Christakopoulos","year":"2015","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B631","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jcin.2014.08.014","article-title":"Procedural outcomes of chronic total occlusion percutaneous coronary intervention: A report from the NCDR (National Cardiovascular Data Registry)","volume":"8","author":"Brilakis","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B632","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jacc.2016.08.034","article-title":"The hybrid algorithm for treating chronic total occlusions in Europe: The RECHARGE registry","volume":"68","author":"Maeremans","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B633","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jacc.2015.03.566","article-title":"Retrograde recanalization of chronic total occlusions in Europe: Procedural, in-hospital, and long-term outcomes from","volume":"65","author":"Galassi","year":"2015","journal-title":"the multicenter ERCTO registry. J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B634","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jcin.2012.01.013","article-title":"Relationship between fractional flow reserve and angiographic and intravascular ultrasound parameters in ostial lesions: Major epicardial vessel versus side branch ostial lesions","volume":"5","author":"Koh","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B635","first-page":"1002","article-title":"Incidence and mechanisms of longitudinal stent deformation associated with Biomatrix, Resolute, Element, and Xience stents: Angiographic and case-by-case review of 1,800 PCIs","volume":"86","author":"Arnous","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B636","first-page":"212H","article-title":"New technique of aorto-ostial stent placement","volume":"96","author":"Szabo","year":"2005","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B637","doi-asserted-by":"crossref","first-page":"801","DOI":"10.4244\/EIJV5I7A134","article-title":"Szabo technique versus conventional angiographic placement in bifurcations 010-001 of Medina and in aorto-ostial stenting: Angiographic and procedural results","volume":"5","author":"Gutierrez-Chico","year":"2010","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B638","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(11)60404-2","article-title":"Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial","volume":"377","author":"Jolly","year":"2011","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B639","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.4244\/EIJV8I11A192","article-title":"Consensus document on the radial approach in percutaneous cardiovascular interventions: Position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology","volume":"8","author":"Hamon","year":"2013","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B640","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B641","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcin.2016.04.014","article-title":"Radial versus femoral access for coronary interventions across the entire spectrum of patients with coronary artery disease: A meta-analysis of randomized trials","volume":"9","author":"Ferrante","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B642","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/eurheartj\/ehv500","article-title":"Everolimus-eluting bioresorbable stent vs durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: Results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial","volume":"37","author":"Sabate","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B643","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: A meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B644","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","article-title":"A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B645","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","article-title":"Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds","volume":"65","author":"Puricel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B646","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan","volume":"36","author":"Kimura","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B647","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2015.09.054","article-title":"ABSORB China Investigators. Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: ABSORB China trial","volume":"66","author":"Gao","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B648","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B649","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B650","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4244\/EIJ-D-17-00492","article-title":"Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: A meta-analysis of randomised trials","volume":"13","author":"Cassese","year":"2018","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B651","first-page":"314","article-title":"Impact of intravascular ultrasound-guided stenting on long-term clinical outcome: A meta-analysis of available studies comparing intravascular ultrasound-guided and angiographically guided stenting","volume":"59","author":"Casella","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B652","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCULATIONAHA.113.003942","article-title":"Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: The assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study","volume":"129","author":"Witzenbichler","year":"2014","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B653","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jcin.2015.07.024","article-title":"Comparison of stent expansion guided by optical coherence tomography versus intravascular ultrasound: The ILUMIEN II study (observational study of optical coherence tomography [OCT] in patients undergoing fractional flow reserve [FFR] and percutaneous coronary intervention)","volume":"8","author":"Maehara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B654","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jacc.2013.04.015","article-title":"Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results","volume":"62","author":"Maeng","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B655","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1161\/CIRCULATIONAHA.109.888297","article-title":"Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: The British Bifurcation Coronary Study: old, new, and evolving strategies","volume":"121","author":"Hildick-Smith","year":"2010","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B656","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCINTERVENTIONS.110.958512","article-title":"Simple or complex stenting for bifurcation coronary lesions: A patient-level pooled-analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study","volume":"4","author":"Behan","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B657","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jacc.2010.10.023","article-title":"A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: Results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial","volume":"57","author":"Chen","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B658","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCINTERVENTIONS.109.868091","article-title":"Double versus single stenting for coronary bifurcation lesions: A meta-analysis","volume":"2","author":"Katritsis","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B659","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jcin.2011.03.021","article-title":"Long-term outcome of percutaneous coronary intervention for chronic total occlusions","volume":"4","author":"Mehran","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B660","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.amjcard.2011.05.021","article-title":"Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus","volume":"108","author":"Claessen","year":"2011","journal-title":"Am J Cardiol"},{"key":"2025110203570931700_ezy289-B661","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jcin.2012.01.012","article-title":"Successful recanalization of chronic total occlusions is associated with improved long-term survival","volume":"5","author":"Jones","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B662","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1161\/CIRCOUTCOMES.108.825760","article-title":"Quantifying the early health status benefits of successful chronic total occlusion recanalization: Results from the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial","volume":"3","author":"Grantham","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025110203570931700_ezy289-B663","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ahj.2010.04.015","article-title":"Effectiveness of recanalization of chronic total occlusions: A systematic review and meta-analysis","volume":"160","author":"Joyal","year":"2010","journal-title":"Am Heart J"},{"key":"2025110203570931700_ezy289-B664","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","article-title":"Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: Appropriateness of including bleeding as a component of a quadruple end point","volume":"51","author":"Ndrepepa","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B665","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Schomig","year":"1996","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B666","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/eurheartj\/ehv717","article-title":"Pre-treatment with P2Y12 inhibitors in ACS patients: Who, when, why, and which agent?","volume":"37","author":"Sibbing","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B667","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B668","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1001\/jama.2012.50788","article-title":"Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis","volume":"308","author":"Bellemain-Appaix","year":"2012","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B669","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jama.292.6.696","article-title":"Long-term efficacy of bivalirudin and provisional glycoprotein IIb\/IIIa blockade vs heparin and planned glycoprotein IIb\/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial","volume":"292","author":"Lincoff","year":"2004","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B670","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJMoa0802944","article-title":"Bivalirudin versus unfractionated heparin during percutaneous coronary intervention","volume":"359","author":"Kastrati","year":"2008","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B671","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1093\/eurheartj\/ehq330","article-title":"ISAR-REACT 3A: A study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention","volume":"31","author":"Schulz","year":"2010","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B672","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJMoa052711","article-title":"STEEPLE Investigators. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention","volume":"355","author":"Montalescot","year":"2006","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B673","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(13)61615-3","article-title":"Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: A pooled analysis of patient-level data","volume":"382","author":"Steg","year":"2013","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B674","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jacc.2004.03.042","article-title":"The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: The ADVANCE Trial","volume":"44","author":"Valgimigli","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B675","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa031859","article-title":"A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel","volume":"350","author":"Kastrati","year":"2004","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B676","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jacc.2010.10.030","article-title":"Efficacy and safety of glycoprotein IIb\/IIIa inhibitors during elective coronary revascularization: A meta-analysis of randomized trials performed in the era of stents and thienopyridines","volume":"57","author":"Winchester","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B677","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B678","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B679","first-page":"550","article-title":"Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: Results of","volume":"56","author":"Di Sciascio","year":"2010","journal-title":"the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial. J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B680","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehn169","article-title":"Clopidogrel pre-treatment in stable angina: For all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI? A randomized multicentre trial PRAGUE-8","volume":"29","author":"Widimsky","year":"2008","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B681","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"key":"2025110203570931700_ezy289-B682","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2013I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"key":"2025110203570931700_ezy289-B683","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists C","year":"2009","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B684","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","article-title":"Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the clopidogrel aspirin stent international cooperative study (CLASSICS)","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B685","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc3001.093435","article-title":"Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population","volume":"104","author":"Taniuchi","year":"2001","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B686","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.CIR.101.6.590","article-title":"A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents","volume":"101","author":"Muller","year":"2000","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B687","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.105.559088","article-title":"Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: Results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial","volume":"112","author":"von Beckerath","year":"2005","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B688","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2006.04.090","article-title":"A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: The ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial","volume":"48","author":"Montalescot","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B689","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1136\/bmj.e553","article-title":"Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: Systematic review and meta-analysis","volume":"344","author":"Silvain","year":"2012","journal-title":"BMJ"},{"key":"2025110203570931700_ezy289-B690","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B691","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs 12 months of clopidogrel therapy after drug-eluting stenting","volume":"36","author":"Schulz-Schupke","year":"2015","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B692","doi-asserted-by":"crossref","first-page":"e003145","DOI":"10.1161\/CIRCINTERVENTIONS.115.003145","article-title":"Six versus 12 months of dual antiplatelet therapy after implantation of biodegradable polymer sirolimus-eluting stent: Randomized substudy of the I-LOVE-IT 2 trial","volume":"9","author":"Han","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B693","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jcin.2016.04.036","article-title":"6-month versus 12-month dual-antiplatelet therapy following long everolimus-eluting stent implantation: The IVUS-XPL randomized clinical trial","volume":"9","author":"Hong","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B694","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jama.2015.1671","article-title":"Antiplatelet therapy duration following bare metal or drug-eluting coronary stents: The dual antiplatelet therapy randomized clinical trial","volume":"313","author":"Kereiakes","year":"2015","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B695","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B696","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: The OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B697","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/S0140-6736(15)60263-X","article-title":"Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: A pairwise and Bayesian network meta-analysis of randomised trials","volume":"385","author":"Palmerini","year":"2015","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B698","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation: A systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Giustino","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B699","doi-asserted-by":"crossref","first-page":"h1618","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials","volume":"350","author":"Navarese","year":"2015","journal-title":"BMJ"},{"key":"2025110203570931700_ezy289-B700","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B701","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B702","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B703","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: A meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B704","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jacc.2006.05.058","article-title":"A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: Enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes","volume":"48","author":"Cohen","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B705","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B706","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(14)61216-2","article-title":"Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: A meta-analysis of randomised controlled trials","volume":"384","author":"Cavender","year":"2014","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B707","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4244\/EIJY14M08_01","article-title":"Bivalirudin versus heparin in patients treated with percutaneous coronary intervention: A meta-analysis of randomised trials","volume":"11","author":"Cassese","year":"2015","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B708","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijcard.2016.01.206","article-title":"Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials","volume":"209","author":"Zhang","year":"2016","journal-title":"Int J Cardiol"},{"key":"2025110203570931700_ezy289-B709","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMoa1706443","article-title":"Bivalirudin versus heparin monotherapy in myocardial infarction","volume":"377","author":"Erlinge","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B710","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00392-018-1251-1","article-title":"Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials","volume":"107","author":"N\u00fchrenberg","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2025110203570931700_ezy289-B711","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Fifth Organization to Assess Strategies in Acute Ischemic Syndromes I","year":"2006","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B712","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B713","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B714","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B715","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(18)30493-8","article-title":"6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): A randomised, open-label, non-inferiority trial","volume":"391","author":"Hahn","year":"2018","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B716","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/eurheartj\/ehx175","article-title":"Benefit of switching dual antiplatelet therapy after acute coronary syndrome: The TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study","volume":"38","author":"Cuisset","year":"2017","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B717","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(17)32155-4","article-title":"Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): A randomised, open-label, multicentre trial","volume":"390","author":"Sibbing","year":"2017","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B718","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/CIRCULATIONAHA.117.031164","article-title":"International expert consensus on switching platelet P2Y12 receptor-inhibiting therapies","volume":"136","author":"Angiolillo","year":"2017","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B719","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","article-title":"Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B720","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B721","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1093\/eurheartj\/ehr373","article-title":"Antiplatelet agents for the treatment and prevention of atherothrombosis","volume":"32","author":"Patrono","year":"2011","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B722","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B723","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"issue":"9748","key":"2025110203570931700_ezy289-B724","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B725","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.297.6.591","article-title":"Routine upstream initiation vs deferred selective use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: The ACUITY Timing trial","volume":"297","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B726","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis","volume":"276","author":"Oler","year":"1996","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B727","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.2010.1320","article-title":"Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: The FUTURA\/OASIS-8 randomized trial","volume":"304","author":"FUTURA\/OASIS-Trial Group 8","year":"2010","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B728","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1507854","article-title":"Bivalirudin or unfractionated heparin in acute coronary syndromes","volume":"373","author":"Valgimigli","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B729","first-page":"1034","article-title":"Three, six or twelve months of dual antiplatelet therapy after drug-eluting stent implantation in patients with or without acute coronary syndromes: An individual patient data pairwise and network meta-analysis of six randomized trials and 11,473 patients","volume":"38","author":"Palmerini","year":"2017","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B730","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: A pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B731","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/eurheartj\/ehv531","article-title":"Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: Insights from PEGASUS-TIMI 54","volume":"37","author":"Bonaca","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B732","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B733","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijcard.2015.08.058","article-title":"Impact of greater than 12-month dual antiplatelet therapy duration on mortality: Drug-specific or a class-effect? A meta-analysis","volume":"201","author":"Costa","year":"2015","journal-title":"Int J Cardiol"},{"key":"2025110203570931700_ezy289-B734","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jcin.2015.10.001","article-title":"Benefits and risks of extended dual antiplatelet therapy after everolimus-eluting stents","volume":"9","author":"Hermiller","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B735","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.116.024823","article-title":"Prasugrel versus ticagrelor in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: Multicenter randomized PRAGUE-18 study","volume":"134","author":"Motovska","year":"2016","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B736","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B737","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(11)60876-3","article-title":"Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: The international randomised open-label ATOLL trial","volume":"378","author":"Montalescot","year":"2011","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B738","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","article-title":"Platelet glycoprotein IIb\/IIIa inhibition with coronary stenting for acute myocardial infarction","volume":"344","author":"Montalescot","year":"2001","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B739","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMoa013404","article-title":"Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction","volume":"346","author":"Stone","year":"2002","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B740","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/eurheartj\/ehp118","article-title":"Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: A meta-regression analysis of randomized trials","volume":"30","author":"De Luca","year":"2009","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B741","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMoa0706816","article-title":"Facilitated PCI in patients with ST-elevation myocardial infarction","volume":"358","author":"Ellis","year":"2008","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B742","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(08)61235-0","article-title":"Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): A multicentre, double-blind, randomised controlled trial","volume":"372","author":"Van't Hof","year":"2008","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B743","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.109.927582","article-title":"Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis","volume":"122","author":"Steg","year":"2010","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B744","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1311096","article-title":"Bivalirudin started during emergency transport for primary PCI","volume":"369","author":"Steg","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B745","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B746","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","author":"Shahzad","year":"2014","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B747","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/eurheartj\/ehv381","article-title":"Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: A nationwide study","volume":"37","author":"Hansson","year":"2016","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B748","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/ejcts\/ezw149","article-title":"Coronary artery bypass grafting-related bleeding complications in patients treated with dual antiplatelet treatment","volume":"50","author":"Tomsic","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B749","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jamacardio.2016.3028","article-title":"Safety of preoperative use of ticagrelor with or without aspirin compared with aspirin alone in patients with acute coronary syndromes undergoing coronary artery bypass grafting","volume":"1","author":"Gherli","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2025110203570931700_ezy289-B750","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jacc.2010.03.108","article-title":"Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery","volume":"56","author":"Kwak","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B751","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.athoracsur.2010.09.022","article-title":"Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines","volume":"91","author":"Ranucci","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B752","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/bja\/aeu315","article-title":"Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery","volume":"113","author":"Ranucci","year":"2014","journal-title":"Br J Anaesth"},{"key":"2025110203570931700_ezy289-B753","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jacc.2013.05.029","article-title":"Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention","volume":"62","author":"Lamberts","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B754","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: An open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B755","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of triple therapy in patients requiring oral anticoagulation after drug-eluting stent implantation: The ISAR-TRIPLE trial","volume":"65","author":"Fiedler","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B756","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B757","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B758","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial","volume":"127","author":"Dans","year":"2013","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B759","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ahj.2017.11.005","article-title":"Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial","volume":"197","author":"Kopin","year":"2018","journal-title":"Am Heart J"},{"key":"2025110203570931700_ezy289-B760","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B761","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/eurheartj\/ehq151","article-title":"The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis","volume":"31","author":"Post","year":"2010","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B762","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jtcvs.2016.06.042","article-title":"Peri- and postoperative care after coronary artery bypass grafting in low versus high volume centers","volume":"152","author":"Kim","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B763","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/jamasurg.2013.3649","article-title":"Understanding the volume-outcome effect in cardiovascular surgery: The role of failure to rescue","volume":"149","author":"Gonzalez","year":"2014","journal-title":"JAMA Surg"},{"key":"2025110203570931700_ezy289-B764","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMsa035205","article-title":"Surgeon volume and operative mortality in the United States","volume":"349","author":"Birkmeyer","year":"2003","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B765","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.athoracsur.2004.12.002","article-title":"Is hospital procedure volume a reliable marker of quality for coronary artery bypass surgery? A comparison of risk and propensity adjusted operative and midterm outcomes","volume":"79","author":"Zacharias","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"2025110203570931700_ezy289-B766","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jtcvs.2011.10.043","article-title":"Quality, not volume, determines outcome of coronary artery bypass surgery in a university-based community hospital network","volume":"143","author":"Kurlansky","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025110203570931700_ezy289-B767","doi-asserted-by":"crossref","first-page":"696","DOI":"10.7326\/0003-4819-150-10-200905190-00007","article-title":"Shop for quality or volume? Volume, quality, and outcomes of coronary artery bypass surgery","volume":"150","author":"Auerbach","year":"2009","journal-title":"Ann Intern Med"},{"key":"2025110203570931700_ezy289-B768","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezw300","article-title":"EACTS clinical statement: Guidance for the provision of adult cardiac surgery","volume":"50","author":"Pagano","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025110203570931700_ezy289-B769","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/CIRCULATIONAHA.104.528455","article-title":"Volume-outcome relationships for percutaneous coronary interventions in the stent era","volume":"112","author":"Hannan","year":"2005","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B770","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1001\/jama.284.24.3139","article-title":"Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent","volume":"284","author":"McGrath","year":"2000","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B771","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/CIRCULATIONAHA.105.578195","article-title":"Relation between hospital specialization with primary percutaneous coronary intervention and clinical outcomes in ST-segment elevation myocardial infarction: National Registry of Myocardial Infarction-4 analysis","volume":"113","author":"Nallamothu","year":"2006","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B772","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/eurheartj\/ehi843","article-title":"Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry","volume":"27","author":"Spaulding","year":"2006","journal-title":"Eur Heart J"},{"key":"2025110203570931700_ezy289-B773","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1161\/hc3901.096668","article-title":"Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state","volume":"104","author":"Vakili","year":"2001","journal-title":"Circulation"},{"key":"2025110203570931700_ezy289-B774","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM200005253422106","article-title":"The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators","volume":"342","author":"Canto","year":"2000","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B775","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jcin.2016.08.011","article-title":"Impact of operator experience and volume on outcomes after left main coronary artery percutaneous coronary intervention","volume":"9","author":"Xu","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110203570931700_ezy289-B776","first-page":"31","article-title":"Curriculum and syllabus for Interventional Cardiology subspecialty training in Europe","volume":"2","author":"Di Mario","year":"2006","journal-title":"EuroIntervention"},{"key":"2025110203570931700_ezy289-B777","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B778","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7326\/0003-4819-143-9-200511010-00010","article-title":"Meta-analysis: Secondary prevention programs for patients with coronary artery disease","volume":"143","author":"Clark","year":"2005","journal-title":"Ann Intern Med"},{"key":"2025110203570931700_ezy289-B779","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1001\/jama.290.1.86","article-title":"Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: A systematic review","volume":"290","author":"Critchley","year":"2003","journal-title":"JAMA"},{"key":"2025110203570931700_ezy289-B780","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"2025110203570931700_ezy289-B781","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists Collaboration","year":"2010","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B782","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2017.08.037","article-title":"Antiplatelet agents for the treatment and prevention of coronary atherothrombosis","volume":"70","author":"Patrono","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2025110203570931700_ezy289-B783","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B784","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"key":"2025110203570931700_ezy289-B785","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"2025110203570931700_ezy289-B786","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2013.07.035","article-title":"Prognostic value of stress imaging after revascularization: A systematic review of stress echocardiography and stress nuclear imaging","volume":"167","author":"Harb","year":"2014","journal-title":"Am Heart J"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/55\/1\/4\/64103107\/ejcts_55_1_4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/55\/1\/4\/64103107\/ejcts_55_1_4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:58:31Z","timestamp":1762073911000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/55\/1\/4\/5079878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":787,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezy289","relation":{},"ISSN":["1010-7940","1873-734X"],"issn-type":[{"value":"1010-7940","type":"print"},{"value":"1873-734X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,8,27]]}}}